Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Pathways in clear cell renal cell carcinoma WP4018,0.0008249611260919209,2.4407894736842106,17.330030674770516,"['SETD2', 'TGFB2', 'CREBBP', 'KSR1', 'MDH1', 'ARNT', 'ENO1', 'ENO2', 'HIF1A', 'RPTOR', 'ACLY', 'LDHB', 'LDHA', 'PKM', 'AKT1S1', 'LDHD', 'ME1', 'EP300', 'ENPP3', 'GAPDH', 'KCNJ2']",0.15451080814286666,0,0,21
2,Histone Modifications WP2369,0.0008656856754409986,3.148342642059252,22.20207666208795,"['SETD5', 'SETD2', 'KMT2A', 'SMYD5', 'SETD6', 'KMT2C', 'SETD1A', 'H3F3A', 'SETDB2', 'EHMT1', 'SETBP1', 'AEBP2', 'NSD1', 'SMYD3']",0.15451080814286666,0,0,14
3,Glycolysis in senescence WP5049,0.0008948502402096525,8.617706821480406,60.486427572377515,"['RB1', 'LDHA', 'PRKAA1', 'PKM', 'ENO1', 'GAPDH']",0.15451080814286666,0,0,6
4,Type 2 papillary renal cell carcinoma WP4241,0.0013352001732994064,3.5952958292919495,23.796091228346185,"['EGLN1', 'SETD2', 'TGFB2', 'CREBBP', 'EGLN2', 'CADM2', 'CTSK', 'DVL2', 'EP300', 'ARNT', 'HIF1A']",0.17290842244227314,0,0,11
5,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.005410570322798296,4.189214262665376,21.865188154825475,"['EGLN1', 'PRKAA1', 'LDHA', 'PDHA1', 'CUL3', 'RPS6', 'HIF1A']",0.48119290909073015,0,0,7
6,Parkinson's disease pathway WP2371,0.006062758584792469,2.994223622556148,15.287279294346021,"['PRKN', 'ATXN2', 'UCHL1', 'PINK1', 'UBB', 'APAF1', 'LRRK2', 'HTRA2', 'UBE2L6', 'UBE2G1']",0.48119290909073015,0,0,10
7,Fragile X Syndrome  WP4549,0.007374147048515852,1.8584675451439727,9.124657561864082,"['SH3GL3', 'NTRK2', 'DUSP3', 'KCNC1', 'CLTC', 'TECR', 'DICER1', 'PIK3CB', 'GRIN2B', 'GPHN', 'GRM1', 'DNM2', 'PPP1CA', 'RPTOR', 'GRIN2A', 'RPS6KB1', 'MKNK1', 'AKT1S1', 'NF1', 'KRAS', 'RAF1', 'GABRD', 'EIF4G1', 'HCN1']",0.48119290909073015,0,0,24
8,3q29 copy number variation syndrome WP4906,0.007639333180187965,2.341213278064538,11.412115262827884,"['DYNC2H1', 'STAT5B', 'TFRC', 'MAD2L1BP', 'FBXO45', 'HIF1A', 'PIGX', 'BRINP1', 'WDR60', 'UBE2N', 'UBXN7', 'PIGM', 'DYNLRB1', 'PAK2']",0.48119290909073015,0,0,14
9,Regulation of Actin Cytoskeleton WP51,0.008962670675272531,1.752159784417849,8.260885010032679,"['CHRM3', 'CHRM1', 'ROCK1', 'PIK3R4', 'PIK3CB', 'ARHGAP35', 'FGD1', 'PIK3C2B', 'CFL2', 'RAC3', 'PIP4K2C', 'MYH10', 'PAK2', 'WASF2', 'ACTN1', 'MSN', 'RRAS2', 'SSH2', 'SSH3', 'PTK2', 'SSH1', 'DIAPH3', 'APC', 'ARHGEF4', 'KRAS', 'RAF1', 'ARHGEF7']",0.48119290909073015,0,0,27
10,TNF-alpha signaling pathway WP231,0.009289438399434946,1.9814289544614256,9.27086271910526,"['MAP3K3', 'CREBBP', 'APAF1', 'KSR1', 'CHUK', 'BAD', 'TNFAIP3', 'OTUD7B', 'KSR2', 'MAPK9', 'TBK1', 'PSMD2', 'RFK', 'MADD', 'MAP3K8', 'KRAS', 'RAF1', 'GLUL', 'MAP3K14']",0.48119290909073015,0,0,19
11,Glycolysis and Gluconeogenesis WP534,0.013876280643390759,2.5657849179419707,10.975335688425236,"['LDHB', 'LDHA', 'PDHA1', 'PKM', 'MDH1', 'PGAM1', 'GOT2', 'ENO1', 'ENO2', 'GAPDH']",0.588146974687291,0,0,10
12,Thiamine metabolic pathways WP4297,0.016999300704558903,5.739584340260996,23.386413186244393,"['BCKDK', 'PDHA1', 'TPK1', 'SLC19A3']",0.588146974687291,0,0,4
13,Cell cycle WP179,0.018059011447150008,1.7395749058352665,6.982845842231238,"['RB1', 'SMAD2', 'TGFB2', 'SMAD4', 'CDKN1B', 'HDAC1', 'ANAPC10', 'CDC25B', 'SMC1B', 'CCNB3', 'MAD2L2', 'CCNA1', 'RBL1', 'CCND1', 'PTTG2', 'ORC2', 'MCM3', 'EP300', 'ATM', 'MAD1L1', 'YWHAG', 'MCM2']",0.588146974687291,0,0,22
14,Pathways affected in adenoid cystic carcinoma WP3651,0.018478672813809206,2.053701519461597,8.196606242305695,"['MAGI1', 'CEBPA', 'SETD2', 'CREBBP', 'KMT2C', 'MGA', 'MAGI2', 'JMJD1C', 'FOXO3', 'NSD1', 'EP300', 'ATM', 'RAF1', 'KDM6A']",0.588146974687291,0,0,14
15,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.022141448142282142,3.3127163112649325,12.622456030892671,"['SMAD4', 'DNMT1', 'CREBBP', 'EP300', 'ATM', 'FOXO3']",0.588146974687291,0,0,6
16,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.023918779530922998,1.9728975611614243,7.36500686766541,"['PRKN', 'PSMD12', 'HSPA5', 'UBE2L6', 'UBE2G1', 'TUBB4B', 'TUBA4A', 'TUBA1B', 'PSMC6', 'PSMC3', 'TUBB3', 'PSMD2', 'PSMD3', 'STUB1']",0.588146974687291,0,0,14
17,Androgen receptor signaling pathway WP138,0.024627651978444562,1.8242493756896452,6.756810634352482,"['RB1', 'CREBBP', 'SMAD4', 'UBE2I', 'ROCK1', 'HDAC1', 'NCOA3', 'RNF6', 'PIAS2', 'PTK2', 'CCND1', 'KAT5', 'SP1', 'PRDX1', 'ZNF318', 'EP300', 'STUB1']",0.588146974687291,0,0,17
18,miRNA regulation of DNA damage response WP1530,0.027047884221307238,1.9348264654238427,6.985006980794736,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'H2AFX', 'CCNB3', 'RAD52', 'PIDD1', 'CCND1', 'RRM2B', 'CDK5', 'CCNG1', 'TLK2', 'ATM']",0.588146974687291,0,0,14
19,Integrated Cancer Pathway WP1971,0.027509217593669234,2.244455889481338,8.064855539585729,"['ATF1', 'RB1', 'SMAD2', 'BARD1', 'MRE11', 'CDKN1B', 'POU2F1', 'BAD', 'ATM', 'CDC25B']",0.588146974687291,0,0,10
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.027567979506424853,7.171980676328502,25.75530226373735,"['COX8A', 'GSTP1', 'COX5A']",0.588146974687291,0,0,3
21,Molybdenum cofactor (Moco) biosynthesis WP4507,0.027567979506424853,7.171980676328502,25.75530226373735,"['MOCS2', 'AOX1', 'GPHN']",0.588146974687291,0,0,3
22,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.02793965831253658,2.1355807796156974,7.640484769947343,"['RPTOR', 'NTRK2', 'PRKAA1', 'GRIN2A', 'RPS6KB1', 'NF1', 'KRAS', 'PIK3CB', 'CACNA1C', 'GRIN2B', 'GRM1']",0.588146974687291,0,0,11
23,miRNAs involved in DNA damage response WP1545,0.028664521301811085,3.5877659574468086,12.744085922262867,"['RAD52', 'CDKN1B', 'CCND1', 'H2AFX', 'ATM']",0.588146974687291,0,0,5
24,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.028664521301811085,3.5877659574468086,12.744085922262867,"['ACLY', 'PDHA1', 'MDH1', 'ACO1', 'IDH3A']",0.588146974687291,0,0,5
25,Type II diabetes mellitus WP1584,0.028664521301811085,3.5877659574468086,12.744085922262867,"['SURF1', 'KCNJ11', 'INSR', 'CACNA1A', 'PHKA2']",0.588146974687291,0,0,5
26,Leptin signaling pathway WP2034,0.029520890621369818,1.8587262491203378,6.547655236272021,"['STAT5B', 'GSK3A', 'PRKAA1', 'CISH', 'CHUK', 'ROCK1', 'BAD', 'RPS6', 'PTK2', 'CCND1', 'RPS6KB1', 'SP1', 'CFL2', 'RAF1', 'SOCS7']",0.588146974687291,0,0,15
27,TGF-beta Signaling Pathway WP366,0.031972388729724036,1.6062420080511484,5.530102662273286,"['SMAD2', 'SMAD4', 'CREBBP', 'UBE2I', 'ROCK1', 'ZFYVE9', 'HDAC1', 'NEDD4L', 'NUP153', 'PIAS2', 'PTK2', 'MAPK9', 'EID2', 'ITCH', 'RBL1', 'CCND1', 'SP1', 'PRKAR2A', 'EP300', 'RAF1', 'DCP1A', 'PAK2', 'RNF111']",0.6133961985924834,0,0,23
28,Ciliary landscape WP4352,0.035595620775575494,1.4400392541707556,4.8032979648510175,"['RB1', 'POM121', 'PSMD12', 'GDI1', 'HDAC1', 'IFT172', 'SSNA1', 'VPS4A', 'HTRA2', 'NEFM', 'TMED1', 'BBS5', 'CREBBP', 'RNGTT', 'RHBDD2', 'H3F3A', 'RANBP9', 'ARMC8', 'ACSL3', 'MYL6', 'EHD3', 'COPS6', 'PSMC6', 'APC', 'WDR60', 'VAPB', 'GLB1', 'GID8', 'EXOC4', 'MCM3', 'CD2BP2', 'DYNLRB1', 'CALM1', 'EXOC2', 'MCM2']",0.6193980368837858,0,0,35
29,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.03580019493667218,2.8706337687469765,9.558641893442925,"['RB1', 'PRKAA1', 'MDH1', 'SCO2', 'GOT2', 'HMGA1']",0.6193980368837858,0,0,6
30,Computational Model of Aerobic Glycolysis WP4629,0.036440130455535985,4.09915072844024,13.576734109732149,"['LDHA', 'PKM', 'ENO1', 'GAPDH']",0.6193980368837858,0,0,4
31,ATM Signaling Network in Development and Disease  WP3878,0.03706822228455089,2.1121439365857833,6.95950417205784,"['PTPA', 'PRKAA1', 'MRE11', 'KAT5', 'CDK5', 'H2AFX', 'ATM', 'CEP63', 'LBR', 'RNF40']",0.6193980368837858,0,0,10
32,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.043907871154775846,5.378623188405797,16.811756378237604,"['MRE11', 'DROSHA', 'ATM']",0.6252821363053613,0,0,3
33,Insulin signaling in adipocytes (diabetic condition) WP3635,0.043907871154775846,5.378623188405797,16.811756378237604,"['RPS6KB1', 'INSR', 'RPS6']",0.6252821363053613,0,0,3
34,Insulin signaling in adipocytes (normal condition) WP3634,0.043907871154775846,5.378623188405797,16.811756378237604,"['RPS6KB1', 'INSR', 'RPS6']",0.6252821363053613,0,0,3
35,DNA damage response WP707,0.04440319884015484,1.8310869979059585,5.702817485979242,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'H2AFX', 'CCNB3', 'RAD52', 'PIDD1', 'CCND1', 'RRM2B', 'CDK5', 'TLK2', 'ATM']",0.6252821363053613,0,0,13
36,Alzheimer's disease WP2059,0.045112611479387804,1.7383381924198251,5.386403315838532,"['APAF1', 'BAD', 'CACNA1D', 'CACNA1C', 'CACNA1F', 'GRIN2B', 'RYR3', 'APH1A', 'VMP1', 'GRIN2A', 'PPP3CC', 'CDK5', 'CAPN2', 'CALM1', 'GAPDH']",0.6252821363053613,0,0,15
37,7q11.23 copy number variation syndrome WP4932,0.04629522893485345,1.6376235794142104,5.031952780303539,"['RB1', 'TSG101', 'CLTC', 'H2AFX', 'UBE2E1', 'FZD9', 'HMGA1', 'UBE2L6', 'VPS37A', 'ATP5F1D', 'MLXIPL', 'CLDN4', 'TBL2', 'BCL7B', 'GAPDH', 'PRKG1', 'CLASP1', 'CLASP2']",0.6252821363053613,0,0,18
38,Proteoglycan biosynthesis WP4784,0.04804887589823235,2.9894019987105094,9.074438994624646,"['EXT2', 'CANT1', 'CHSY1', 'B3GAT3', 'PAPSS2']",0.6252821363053613,0,0,5
39,Aryl Hydrocarbon Receptor Netpath WP2586,0.04933854554497841,2.0843023255813953,6.271769176048726,"['RB1', 'CDKN1B', 'AIP', 'NF1', 'EP300', 'ARNT', 'KRAS', 'CD36', 'RAF1']",0.6252821363053613,0,0,9
40,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.04949144322108072,3.5865152247462544,10.78090512466883,"['GRM3', 'GRM4', 'GRM7', 'GRM1']",0.6252821363053613,0,0,4
41,RalA downstream regulated genes WP2290,0.04949144322108072,3.5865152247462544,10.78090512466883,"['RALBP1', 'RAC3', 'KRAS', 'EXOC2']",0.6252821363053613,0,0,4
42,MECP2 and Associated Rett Syndrome WP3584,0.05503739554697466,1.7617512364901997,5.10862476884016,"['GAMT', 'MPP1', 'RBFOX1', 'GRID1', 'HDAC1', 'RPS6', 'TET2', 'MYT1', 'FUT8', 'SP1', 'NF1', 'GRIA3', 'CDON']",0.6529908741952187,0,0,13
43,Autophagy WP4923,0.05651149763275286,2.2834858752090117,6.561165457178796,"['RPTOR', 'PRKAA1', 'ATG101', 'ATG9A', 'AKT1S1', 'PIK3R4', 'AMBRA1']",0.6529908741952187,0,0,7
44,Metabolic reprogramming in colon cancer WP4290,0.05661848972142285,2.019031613372093,5.797487096248509,"['ACLY', 'LDHA', 'PDHA1', 'PKM', 'PGAM1', 'GOT2', 'ENO1', 'GAPDH', 'IDH3A']",0.6529908741952187,0,0,9
45,Pancreatic adenocarcinoma pathway WP4263,0.05672700644553059,1.6422251545246198,4.71237309084725,"['RB1', 'SMAD2', 'RALBP1', 'TGFB2', 'SMAD4', 'CHUK', 'BAD', 'PIK3CB', 'TIAM1', 'MAPK9', 'CCND1', 'RPS6KB1', 'RAC3', 'KRAS', 'RAF1', 'PAK2']",0.6529908741952187,0,0,16
46,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.06095212709436022,1.7290093491549803,4.837191576952853,"['ACTN1', 'ITGA2B', 'CACNA2D3', 'CACNA1D', 'CACNA1C', 'CACNA1F', 'CACNG7', 'CACNB3', 'CDH2', 'DMD', 'CACNG2', 'EMD', 'ITGA9']",0.6577994106088927,0,0,13
47,Rett syndrome causing genes WP4312,0.06256428929011196,1.889302752761691,5.236317113108026,"['KDM5B', 'SRRM3', 'GRIN2A', 'TAF1B', 'HDAC1', 'IMPDH2', 'HAP1', 'GABRD', 'GRIN2B', 'SYNE2']",0.6577994106088927,0,0,10
48,Synaptic Vesicle Pathway WP2267,0.06256428929011196,1.889302752761691,5.236317113108026,"['NSF', 'STX1B', 'SYT1', 'CLTC', 'CACNA1B', 'CACNA1A', 'SYN3', 'SLC25A4', 'CPLX1', 'DNM2']",0.6577994106088927,0,0,10
49,HIF1A and PPARG regulation of glycolysis WP2456,0.06398426704034613,4.302608695652174,11.828379241664685,"['LDHA', 'HIF1A', 'GAPDH']",0.6577994106088927,0,0,3
50,Gastric Cancer Network 1 WP2361,0.06472972255516368,2.391711014352524,6.547392115682888,"['CCNA1', 'NUP107', 'RNF216', 'APC', 'H3F3A', 'CEP192']",0.6577994106088927,0,0,6
51,Homologous recombination WP186,0.06476403463523847,3.187798721873154,8.725020565033264,"['RAD52', 'MRE11', 'RPA1', 'ATM']",0.6577994106088927,0,0,4
52,16p11.2 proximal deletion syndrome WP4949,0.0672767329390922,1.6974580759046778,4.581338897520232,"['PAXIP1', 'KMT2C', 'MAZ', 'MSN', 'PPP4R3A', 'CCT6A', 'PPP4R1', 'PPP2R1A', 'TCP1', 'TMEM219', 'CCT7', 'YPEL3', 'BPTF']",0.6701797627394185,0,0,13
53,Integrated breast cancer pathway WP1984,0.07167302895640675,1.43767691556857,3.789199888917523,"['ATF1', 'RB1', 'SMAD2', 'BARD1', 'SMAD4', 'GSK3A', 'USP15', 'MRE11', 'CERK', 'GDI1', 'CHUK', 'HDAC1', 'BAD', 'NCOA3', 'PPP4R3A', 'MYT1', 'CDC25B', 'CCND1', 'SP1', 'NF1', 'EP300', 'ATM', 'KRAS', 'BMPR1A']",0.6905679448679818,0,0,24
54,Hippo-Merlin Signaling Dysregulation WP4541,0.07537870242498028,1.5214083297552599,3.9331912247586014,"['NTRK1', 'NTRK2', 'INSR', 'ITGA2B', 'PTK2', 'CDH7', 'PPP1CA', 'CDH6', 'LATS1', 'CUL4A', 'CCND1', 'CDH2', 'CDH20', 'PRKAR2A', 'CDH10', 'KRAS', 'PAK2', 'ITGA9']",0.6905679448679818,0,0,18
55,Effects of nitric oxide WP1995,0.0759891367904922,7.1690004828585225,18.475696311275993,"['AOX1', 'HBA1']",0.6905679448679818,0,0,2
56,Sulindac Metabolic Pathway WP2542,0.0759891367904922,7.1690004828585225,18.475696311275993,"['MSRA', 'MSRB3']",0.6905679448679818,0,0,2
57,Vitamin B6-dependent and responsive disorders WP4228,0.0759891367904922,7.1690004828585225,18.475696311275993,"['PNPO', 'AASS']",0.6905679448679818,0,0,2
58,Ras signaling WP4223,0.08025235186508942,1.3947968997222,3.5184856623480867,"['RAB5B', 'PIK3CB', 'RASGRP2', 'MAPK9', 'GRIN2A', 'RAC3', 'SHOC2', 'PAK2', 'NTRK1', 'NTRK2', 'RALBP1', 'KSR1', 'CHUK', 'BAD', 'INSR', 'RRAS2', 'KSR2', 'GRIN2B', 'TIAM1', 'GNB2', 'RASA1', 'NF1', 'KRAS', 'RAF1', 'CALM1', 'EXOC2']",0.7117941234496931,0,0,26
59,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.08118085615416923,1.6376767160619996,4.112330404741822,"['SMAD2', 'TGFB2', 'SMAD4', 'DCC', 'BAD', 'MAPK9', 'TBK1', 'CCND1', 'APC', 'RAC3', 'KRAS', 'RAF1', 'EXOC2']",0.7117941234496931,0,0,13
60,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.08244719576637372,1.8455980066445183,4.605869294998467,"['SMAD2', 'TGFB2', 'SMAD4', 'SUN1', 'KRAS', 'EMD', 'LBR', 'SYNE2', 'ADCY5']",0.7117941234496931,0,0,9
61,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.08680480409396162,1.4126996039191162,3.452769654005463,"['NSF', 'NTRK1', 'STAT5B', 'NTRK2', 'PRKAA1', 'DOCK3', 'KSR1', 'CHUK', 'KIDINS220', 'BAD', 'RPS6', 'RANBP9', 'FOXO3', 'EEF2', 'GRIN2B', 'TIAM1', 'MAPK9', 'CDH2', 'CDK5', 'RPS6KB1', 'APC', 'RAF1', 'GRIA3']",0.7192534668798994,0,0,23
62,Gastrin signaling pathway WP4659,0.0872984160391695,1.4862320664485276,3.624062394987428,"['CHGA', 'CDKN1B', 'CHUK', 'ROCK1', 'BAD', 'PRKCE', 'ARHGEF28', 'RPS6', 'ARRB2', 'FOXO3', 'PTK2', 'MAPK9', 'CCND1', 'KAT5', 'RPS6KB1', 'SP1', 'KRAS', 'RAF1']",0.7192534668798994,0,0,18
63,Biotin Metabolism (including IEMs) WP5031,0.0874767729989067,3.5852657004830917,8.73507671855574,"['PCCA', 'HLCS', 'MCCC1']",0.7192534668798994,0,0,3
64,Mesodermal commitment pathway WP2857,0.09358719165368211,1.4368241597661957,3.4036377880416024,"['SMAD2', 'MACF1', 'SMAD4', 'SETD2', 'EMSY', 'ACVR2A', 'MBTD1', 'LATS1', 'EPB41L5', 'EXT2', 'CCDC88A', 'CCND1', 'AEBP2', 'HNF4A', 'CEP250', 'RARB', 'DIP2A', 'WDFY2', 'BMPR1A', 'KDM6A']",0.7574713324469896,0,0,20
65,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.09726350738861675,1.7089075087136163,3.9823208489066824,"['RB1', 'SMAD2', 'CEBPA', 'TGFB2', 'CREBBP', 'APC', 'HDAC1', 'CTSK', 'DICER1', 'EMD']",0.7644541441563439,0,0,10
66,Pathways Regulating Hippo Signaling WP4540,0.09937515197555796,1.517061552991418,3.502672385866115,"['SMAD2', 'NTRK1', 'NTRK2', 'PRKCI', 'PRKAA1', 'PRKCE', 'INSR', 'GNAI3', 'CDH7', 'CDH6', 'LATS1', 'CDH2', 'CDH20', 'PRKAR2A', 'CDH10']",0.7644541441563439,0,0,15
67,Disruption of postsynaptic signaling by CNV WP4875,0.1010473286551953,1.9316590959862983,4.427683827572673,"['NLGN1', 'GRIN2A', 'DLG2', 'DLGAP1', 'GRIN2B', 'GRM1', 'YWHAG']",0.7644541441563439,0,0,7
68,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1010473286551953,1.9316590959862983,4.427683827572673,"['EGLN1', 'LDHA', 'PDHA1', 'PKM', 'BNIP3', 'ARNT', 'HIF1A']",0.7644541441563439,0,0,7
69,MAPK Signaling Pathway WP382,0.10253019180289391,1.290581515311643,2.9394258388792363,"['LRRK2', 'CACNA1B', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'ARRB2', 'CACNA1F', 'RASGRP2', 'CACNA1E', 'CACNA1I', 'MAPK9', 'CACNG7', 'PPP3CC', 'MKNK1', 'RAC3', 'MAP3K8', 'CACNG2', 'PAK2', 'MAP4K4', 'NTRK1', 'NTRK2', 'TGFB2', 'DUSP3', 'CHUK', 'CACNA2D3', 'RRAS2', 'CDC25B', 'CACNB3', 'PPM1B', 'TAOK3', 'RASA1', 'NF1', 'KRAS', 'RAF1', 'MAP3K14']",0.7644541441563439,0,0,35
70,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.10414148509128146,2.0496233326422004,4.636257961787216,"['FGD4', 'RAB4A', 'MFN2', 'RABAC1', 'SBF2', 'DNM2']",0.7644541441563439,0,0,6
71,Ciliopathies WP4803,0.10478039427625563,1.3382141773687937,3.0188621099123147,"['INVS', 'C2CD3', 'IFT172', 'DNAH6', 'PIK3R4', 'PKD2', 'PKD1', 'TTBK2', 'TBC1D32', 'NPHP4', 'RAB28', 'BBS5', 'DYNC2H1', 'CFAP52', 'WDR19', 'SCLT1', 'DNAAF5', 'CPLANE1', 'TTLL5', 'FAM161A', 'WDR60', 'NME7', 'KIAA0586', 'WDPCP', 'B9D2', 'KIZ', 'SDCCAG8']",0.7644541441563439,0,0,27
72,TCA cycle in senescence WP5050,0.11398465474548386,3.0728778467908904,6.673342537993431,"['PDHA1', 'MDH1', 'ME1']",0.7772564061155696,0,0,3
73,Trans-sulfuration pathway WP2333,0.11398465474548386,3.0728778467908904,6.673342537993431,"['DNMT1', 'AHCY', 'MAT2B']",0.7772564061155696,0,0,3
74,Joubert Syndrome WP4656,0.11409448348087914,1.5298742638866782,3.3209414692795773,"['INVS', 'MRE11', 'ARMC9', 'ARL2', 'MYO5A', 'CPLANE1', 'KAT5', 'KIAA0586', 'NPHP4', 'ATM', 'B9D2', 'PCNT', 'BBS5']",0.7772564061155696,0,0,13
75,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.11432727900607319,1.6995486536107711,3.6857942973814652,"['SMAD2', 'FKBP1A', 'MAPK9', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300', 'LTBP3', 'SMAD5']",0.7772564061155696,0,0,9
76,Target Of Rapamycin (TOR) Signaling WP1471,0.11449857273795694,1.8599906779964863,4.030958630919334,"['RPTOR', 'FKBP1A', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'AKT1S1', 'ULK3']",0.7772564061155696,0,0,7
77,miR-517 relationship with ARCN1 and USP1 WP3596,0.11654468672138983,4.779011749557379,10.272392576966542,"['USP1', 'ARCN1']",0.7772564061155696,0,0,2
78,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.11952736818939648,1.9563266921757487,4.155648549312923,"['SMAD2', 'TGFB2', 'SMAD4', 'APC', 'KRAS', 'RAF1']",0.7772564061155696,0,0,6
79,G1 to S cell cycle control WP45,0.12072628719230825,1.5789427740058195,3.3382472101852105,"['RB1', 'CCNA1', 'CREB3', 'CDKN1B', 'CCND1', 'ORC2', 'MCM3', 'RPA1', 'ATM', 'MYT1', 'MCM2']",0.7772564061155696,0,0,11
80,Splicing factor NOVA regulated synaptic proteins WP4148,0.12151760730478779,1.739349915621102,3.666021052148025,"['MAPK9', 'CDH2', 'APLP2', 'KCNMA1', 'NCDN', 'GRIN2B', 'GPHN', 'CLASP1']",0.7772564061155696,0,0,8
81,SARS coronavirus and innate immunity WP4912,0.12300450429003335,2.3903657161269534,5.009093357335732,"['TBK1', 'DDX58', 'TRAF3', 'IKBKE']",0.7772564061155696,0,0,4
82,Urea cycle and associated pathways WP4595,0.12304058938509016,2.109455000568893,4.41981656908192,"['LDHB', 'OAT', 'MDH1', 'GOT2', 'SLC25A13']",0.7772564061155696,0,0,5
83,Endoderm differentiation WP2853,0.1287621094911001,1.3781928338890364,2.825004082940201,"['SMAD2', 'SMAD4', 'SFMBT1', 'FOXN3', 'EMSY', 'CDC73', 'MBTD1', 'MAD2L2', 'TNRC6C', 'EPB41L5', 'CAND1', 'AEBP2', 'APC', 'CEP250', 'DIP2A', 'WDFY2', 'NAA15', 'BPTF', 'BMPR1A']",0.8035996712818054,0,0,19
84,EGF/EGFR signaling pathway WP437,0.13446908909108485,1.3159724162596538,2.6403945956503216,"['ATF1', 'SH3GL3', 'STAT5B', 'MAP3K3', 'RALBP1', 'PRKCI', 'ROCK1', 'NCOA3', 'CBLB', 'PTPN12', 'PTK2', 'EPN1', 'PIK3C2B', 'MAPK9', 'ATXN2', 'ITCH', 'RPS6KB1', 'SP1', 'RASA1', 'REPS2', 'KRAS', 'RAF1', 'STAM2', 'SH3GL2']",0.8141914618938471,0,0,24
85,Eukaryotic Transcription Initiation WP405,0.13492001592730798,1.68807862127902,3.3813449626199734,"['GTF2A2', 'POLR2A', 'GTF2B', 'POLR2C', 'TAF9', 'TAF7', 'POLR3H', 'TAF6']",0.8141914618938471,0,0,8
86,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.1359662966005531,1.8711428030542059,3.7335815046108323,"['RPTOR', 'CDKN1B', 'BAD', 'KRAS', 'PIK3CB', 'FOXO3']",0.8141914618938471,0,0,6
87,Wnt signaling pathway and pluripotency WP399,0.14193785950994897,1.4167753567592452,2.766063931679705,"['PRKCI', 'CREBBP', 'PRKCE', 'LRRK2', 'FZD6', 'FZD9', 'PPM1J', 'LRP6', 'PTPA', 'MAPK9', 'CCND1', 'APC', 'PPP2R1A', 'DVL2', 'EP300']",0.8141914618938471,0,0,15
88,"NAD metabolism, sirtuins and aging WP3630",0.14306386576154195,2.688586956521739,5.2278609099985776,"['FOXO3', 'ROS1', 'HIF1A']",0.8141914618938471,0,0,3
89,Canonical and non-canonical TGF-B signaling WP3874,0.1460677835371441,2.206342714800907,4.244307269379644,"['SMAD2', 'MAPK9', 'SMAD4', 'BMPR1A']",0.8141914618938471,0,0,4
90,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.1460677835371441,2.206342714800907,4.244307269379644,"['SMAD2', 'CDH6', 'SMAD4', 'CDH2']",0.8141914618938471,0,0,4
91,Calcium Regulation in the Cardiac Cell WP536,0.14843285860838765,1.3227788037344823,2.523362679380944,"['CHRM3', 'CHRM1', 'RGS14', 'PRKCE', 'CACNA1B', 'GNAI3', 'CACNA1A', 'CACNA1D', 'CACNA1C', 'ARRB2', 'CACNA1E', 'RYR3', 'ADCY5', 'FKBP1A', 'CACNB3', 'PRKAR2A', 'GNB2', 'CASQ1', 'CALM1', 'RGS6', 'YWHAG']",0.8141914618938471,0,0,21
92,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.14903542208446913,1.639737115185057,3.1213564614742846,"['RPTOR', 'PRKAA1', 'DCAF17', 'ATG101', 'AKT1S1', 'PIK3R4', 'ATG10', 'FTL']",0.8141914618938471,0,0,8
93,TGF-beta Receptor Signaling WP560,0.14903542208446913,1.639737115185057,3.1213564614742846,"['SMAD2', 'FKBP1A', 'MAPK9', 'CREBBP', 'SMAD4', 'ZFYVE9', 'EP300', 'SMAD5']",0.8141914618938471,0,0,8
94,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.15074413770932613,1.329671122656997,2.5159655787895825,"['NTRK2', 'CREBBP', 'TSPYL1', 'THRB', 'HDAC1', 'MAZ', 'ATP1A3', 'HIF1A', 'HADHB', 'DEAF1', 'SP1', 'PRKAR2A', 'NOS1AP', 'EP300', 'TPPP', 'PPARGC1A', 'GAPDH', 'SLC25A4', 'CC2D1A', 'YWHAG']",0.8141914618938471,0,0,20
95,Head and Neck Squamous Cell Carcinoma WP4674,0.15430234789264005,1.459551476574643,2.7276700837371624,"['RB1', 'RPTOR', 'NOTCH2', 'FKBP1A', 'PRKAA1', 'SMAD4', 'CCND1', 'TRAF3', 'CUL3', 'RPS6', 'KRAS', 'PIK3CB']",0.8141914618938471,0,0,12
96,G13 Signaling Pathway WP524,0.16001103764995403,1.673652791222975,3.066989628467758,"['ROCK1', 'RPS6KB1', 'CFL2', 'ARHGDIG', 'PIK3CB', 'CALM1', 'CIT']",0.8141914618938471,0,0,7
97,IL-5 signaling pathway WP127,0.16001103764995403,1.673652791222975,3.066989628467758,"['STAT5B', 'GSK3A', 'RPS6KB1', 'RPS6', 'KRAS', 'FOXO3', 'RAF1']",0.8141914618938471,0,0,7
98,exRNA mechanism of action and biogenesis WP2805,0.16103306468687897,3.5840173829068083,6.544937446375079,"['DROSHA', 'DICER1']",0.8141914618938471,0,0,2
99,miRNA Biogenesis WP2338,0.16103306468687897,3.5840173829068083,6.544937446375079,"['DROSHA', 'DICER1']",0.8141914618938471,0,0,2
100,Pilocytic astrocytoma WP2253,0.16103306468687897,3.5840173829068083,6.544937446375079,"['NF1', 'RAF1']",0.8141914618938471,0,0,2
101,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.16163624203108426,1.324311549333056,2.4134344894228548,"['MAP3K3', 'GSK3A', 'PRKAA1', 'THRB', 'INSR', 'PIK3R4', 'CBLB', 'PIK3CB', 'FOXO3', 'RPTOR', 'MLXIPL', 'MAPK9', 'RPS6KA6', 'RPS6KB1', 'SCD', 'MAP3K8', 'RAF1', 'MAP3K14', 'MAP4K4']",0.8141914618938471,0,0,19
102,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.1626377569690532,1.8871526010383792,3.4275029820251315,"['RB1', 'HDAC1', 'H3F3A', 'MBD2', 'MTA3']",0.8141914618938471,0,0,5
103,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.1626377569690532,1.8871526010383792,3.4275029820251315,"['CCND1', 'APC', 'FZD6', 'LRP6', 'RUNX1T1']",0.8141914618938471,0,0,5
104,Circadian rhythm related genes WP3594,0.16473831565587238,1.2616551578447035,2.275265164261839,"['NLGN1', 'PRKAA1', 'PHLPP1', 'AHCY', 'CHRM1', 'KMT2A', 'HDAC1', 'NPY2R', 'OPRL1', 'ARNTL2', 'ARNTL', 'MAPK9', 'DBP', 'UBC', 'EP300', 'PPARGC1A', 'NTRK1', 'KCNH7', 'ARNT', 'NR2F6', 'PPP1CA', 'PER1', 'CLDN4', 'KCNMA1', 'KLF9', 'CRY1']",0.8141914618938471,0,0,26
105,Translation Factors WP107,0.16583852632204144,1.5372715946843853,2.7620784365685807,"['EIF4A2', 'EIF5A', 'EEF1G', 'EEF2K', 'EIF1AY', 'EIF1AX', 'EIF3G', 'EEF2', 'EIF4G1']",0.8141914618938471,0,0,9
106,AGE/RAGE pathway WP2324,0.16661060803233166,1.4946881564065277,2.6786244834131447,"['SMAD2', 'MAPK9', 'STAT5B', 'CHUK', 'ROCK1', 'SP1', 'INSR', 'MSN', 'RAF1', 'HIF1A']",0.8141914618938471,0,0,10
107,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.17064562118296972,2.048608713664296,3.6222808148089727,"['RAB5B', 'RRAS2', 'KRAS', 'RAF1']",0.820581146132719,0,0,4
108,Wnt signaling in kidney disease WP4150,0.1717595057664493,1.7212191582002903,3.032202947195154,"['INVS', 'MAPK9', 'FZD6', 'DVL2', 'FZD9', 'LRP6']",0.820581146132719,0,0,6
109,G Protein Signaling Pathways WP35,0.17387973156485712,1.376276553986175,2.4076463904912444,"['PRKCI', 'PDE1C', 'PRKCE', 'PDE1A', 'GNAI3', 'AKAP6', 'ADCY5', 'PPP3CC', 'PRKAR2A', 'GNB2', 'AKAP9', 'KRAS', 'CALM1', 'PDE8A']",0.820581146132719,0,0,14
110,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.1742546835416971,2.389694041867955,4.175362688404719,"['CHUK', 'RAF1', 'MAP3K14']",0.820581146132719,0,0,3
111,Energy Metabolism WP1541,0.1792767470410344,1.5508932661475034,2.6657134888747858,"['PRKAA1', 'PPP3CC', 'HDAC1', 'PRMT1', 'EP300', 'NRF1', 'FOXO3', 'PPARGC1A']",0.8252935311946343,0,0,8
112,Genes related to primary cilium development (based on CRISPR) WP4536,0.17932082267662436,1.3352477642988774,2.2947284630153497,"['DYNC2H1', 'TEDC1', 'C2CD3', 'IFT172', 'WDR19', 'ARMC9', 'SCLT1', 'CPLANE1', 'TTBK2', 'WDR60', 'CDK20', 'WDPCP', 'CEP192', 'KIFAP3', 'BBS5', 'CEP44']",0.8252935311946343,0,0,16
113,Proteasome Degradation WP183,0.18003507533782565,1.4640853917912293,2.510326060175148,"['UCHL1', 'PSMD12', 'PSMC6', 'UBB', 'PSMC3', 'PSMD2', 'PSMD3', 'H2AFX', 'UBC', 'PSMB10']",0.8252935311946343,0,0,10
114,Spinal Cord Injury WP2431,0.18218257141111796,1.3455721574344024,2.2911675483560257,"['RB1', 'SEMA6A', 'CDKN1B', 'OMG', 'MIF', 'FOXO3', 'RTN4', 'AQP1', 'FKBP1A', 'C5', 'CCND1', 'PRB1', 'CCNG1', 'SLIT2', 'ROS1']",0.8278120350084133,0,0,15
115,MTHFR deficiency WP4288,0.18411924391305212,1.792674081237911,3.03351228759632,"['DNMT1', 'GRIN2A', 'SGMS1', 'NDUFAF7', 'EHMT1']",0.8293371160605304,0,0,5
116,Regulation of toll-like receptor signaling pathway WP1449,0.1896861565614581,1.3198106828938472,2.1940326639730445,"['CUEDC2', 'CISH', 'CHUK', 'PELI3', 'TNFAIP3', 'PIK3CB', 'RNF41', 'MAPK9', 'TBK1', 'RNF216', 'TRAF3', 'TOLLIP', 'TIFA', 'MAP3K8', 'PTPN6', 'IKBKE']",0.838332221540688,0,0,16
117,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.1909714327061799,1.654906776822597,2.739915671946536,"['CREBBP', 'PPP3CC', 'HDAC1', 'SP1', 'EP300', 'SUPT5H']",0.838332221540688,0,0,6
118,miRNA regulation of prostate cancer signaling pathways WP3981,0.1909714327061799,1.654906776822597,2.739915671946536,"['CREBBP', 'CDKN1B', 'CCND1', 'BAD', 'KRAS', 'RAF1']",0.838332221540688,0,0,6
119,Mitochondrial Gene Expression WP391,0.19652912382381182,1.911905912679233,3.1105650879287,"['SP1', 'NRF1', 'PPARGC1A', 'HCFC1']",0.8412771439665726,0,0,4
120,mRNA Processing WP411,0.19858368604542975,1.2744587720335976,2.060219542115311,"['SRPK2', 'RBM39', 'SF3B2', 'RNGTT', 'PRMT1', 'SFSWAP', 'CELF2', 'PRPF40A', 'DICER1', 'SUPT5H', 'HNRNPK', 'POLR2A', 'DHX15', 'CD2BP2', 'SRSF3', 'SRSF4', 'RNPS1', 'HNRNPH2', 'RBM5']",0.8412771439665726,0,0,19
121,Male infertility WP4673,0.20033452112966588,1.3047244442480224,2.097692519399652,"['NANOS1', 'SLC46A1', 'CREBBP', 'PACRG', 'MTRR', 'CCNT2', 'INSR', 'HMGA1', 'YBX2', 'REC8', 'PUM2', 'ARNTL', 'CCNA1', 'EP300', 'ATM', 'TRIP13']",0.8412771439665726,0,0,16
122,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2019438872502496,1.1424133664075344,1.8275933829998152,"['FAF1', 'CLTC', 'ARRB2', 'LDB2', 'CCND1', 'CAPN2', 'LRRFIP2', 'RPS11', 'IER5', 'PRKG1', 'ACOT9', 'PRKCI', 'PRKCE', 'RPS6', 'ARNT', 'SND1', 'EPN1', 'RCN1', 'EWSR1', 'KATNAL2', 'RHOJ', 'AKT1S1', 'ERG', 'ATP6V0D1', 'RAF1', 'GAPDH', 'PTMA', 'FJX1', 'PRKAA1', 'ROCK1', 'HDAC1', 'FOXO3', 'FUT1', 'GIGYF2', 'MAPK9', 'LDHA', 'FXR2', 'MKNK1', 'DNAJB9', 'CCT7', 'ABCF2', 'PAK2', 'RBM39', 'CREBBP', 'RAB4A', 'TRIP4', 'PTK2', 'PPP1CA', 'ITCH', 'RPS6KB1', 'SPIRE1', 'PTPN9', 'PTPN6', 'COPG1', 'EIF4G1']",0.8412771439665726,0,0,55
123,16p11.2 distal deletion syndrome WP4950,0.20656257755942198,1.707193515704154,2.692503451650587,"['RAB4A', 'PRMT1', 'INSR', 'TUFM', 'SDCCAG8']",0.8412771439665726,0,0,5
124,SARS-CoV-2 mitochondrial interactions WP5038,0.20656257755942198,1.707193515704154,2.692503451650587,"['NDUFB9', 'TBK1', 'DDX58', 'TRAF3', 'IKBKE']",0.8412771439665726,0,0,5
125,Toll-like Receptor Signaling related to MyD88 WP3858,0.20656257755942198,1.707193515704154,2.692503451650587,"['TBK1', 'CHUK', 'TRAF3', 'TOLLIP', 'IKBKE']",0.8412771439665726,0,0,5
126,Cori Cycle WP1946,0.20710188454060247,2.1505797101449273,3.3861832629264184,"['LDHA', 'PGAM1', 'GAPDH']",0.8412771439665726,0,0,3
127,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.20788315526587123,2.8670207629164657,4.503456324197363,"['DHCR24', 'LBR']",0.8412771439665726,0,0,2
128,Glial Cell Differentiation WP2276,0.20788315526587123,2.8670207629164657,4.503456324197363,"['MSN', 'TPPP']",0.8412771439665726,0,0,2
129,CAMKK2  Pathway WP4874,0.21095456874411356,1.5935064236951029,2.479675237172035,"['RPTOR', 'CHRM3', 'EP300', 'ARHGEF7', 'RAF1', 'CALM1']",0.8455786636841296,0,0,6
130,IL-18 signaling pathway WP4754,0.2122108615423491,1.190303100137749,1.8451779519811076,"['SPON1', 'PRKAA1', 'PIGT', 'CD83', 'STOML1', 'TSHZ1', 'MEPCE', 'ITGA2B', 'TNFAIP3', 'ENO1', 'KLC1', 'FUT1', 'RPTOR', 'MAPK9', 'GRM7', 'LONP2', 'CD36', 'LRRFIP1', 'RPS11', 'USP5', 'CHUK', 'IMP3', 'BAD', 'FOXN3', 'EEF2', 'GRIN2B', 'ARFGAP2', 'CLDN4', 'RPS6KB1', 'SP1', 'HDGF']",0.8455786636841296,0,0,31
131,Hepatitis B infection WP4666,0.21846604667284256,1.2509044781719267,1.9027816607137322,"['SMAD2', 'STAT5B', 'TGFB2', 'SMAD4', 'CREBBP', 'ATP6AP1', 'APAF1', 'CHUK', 'DDX58', 'BAD', 'PIK3CB', 'CREB3', 'MAPK9', 'TBK1', 'TRAF3', 'EP300', 'KRAS', 'RAF1', 'IKBKE']",0.8633537475958268,0,0,19
132,AMP-activated protein kinase (AMPK) signaling WP1403,0.2230726248307364,1.3793392743950184,2.0693646275426323,"['RPTOR', 'CCNA1', 'PRKAA1', 'EEF2K', 'RPS6KB1', 'HNF4A', 'INSR', 'PIK3CB', 'ADIPOR1', 'EEF2']",0.8633537475958268,0,0,10
133,Methionine De Novo and Salvage Pathway WP3580,0.22350348680138618,1.792290961817303,2.6854402056699294,"['MSRA', 'AHCY', 'MSRB3', 'MAT2B']",0.8633537475958268,0,0,4
134,Urea cycle and metabolism of amino groups WP497,0.22350348680138618,1.792290961817303,2.6854402056699294,"['GAMT', 'OAT', 'CKB', 'ALDH18A1']",0.8633537475958268,0,0,4
135,DNA damage response (only ATM dependent) WP710,0.2273698266965188,1.281150215188116,1.8976107379510012,"['SMAD4', 'CDKN1B', 'BAD', 'INSR', 'PIK3R4', 'PIK3CB', 'FOXO3', 'PIK3C2B', 'MAPK9', 'CCND1', 'APC', 'DVL2', 'RAC3', 'ATM', 'KRAS']",0.8633537475958268,0,0,15
136,Intraflagellar transport proteins binding to dynein WP4532,0.22984009989943036,1.6294839106734658,2.3959465873505894,"['DYNC2H1', 'WDR60', 'WDR19', 'DYNLRB1', 'DYNC1I1']",0.8633537475958268,0,0,5
137,Lipid Metabolism Pathway WP3965,0.22984009989943036,1.6294839106734658,2.3959465873505894,"['ACLY', 'PRKAA1', 'PDHA1', 'PRKAR2A', 'HILPDA']",0.8633537475958268,0,0,5
138,Nicotine Metabolism WP1600,0.2300054385486952,7.166023166023166,10.531562603184838,['AOX1'],0.8633537475958268,0,0,1
139,Non-small cell lung cancer WP4255,0.2337470782374104,1.337273340018741,1.943747675103109,"['RB1', 'EML4', 'STAT5B', 'CCND1', 'BAD', 'RARB', 'KRAS', 'PIK3CB', 'RAF1', 'FOXO3', 'FHIT']",0.8710862340070401,0,0,11
140,Airway smooth muscle cell contraction WP4962,0.24116903391779695,1.9549407114624506,2.7804285137821134,"['ROCK1', 'GDI1', 'CALM1']",0.8719080130566177,0,0,3
141,Omega-9 FA synthesis WP4724,0.24116903391779695,1.9549407114624506,2.7804285137821134,"['SCD', 'ELOVL3', 'ACSL3']",0.8719080130566177,0,0,3
142,DNA IR-damage and cellular response via ATR WP4016,0.24291271571088718,1.3041330333906753,1.8454174848949476,"['BARD1', 'RAD52', 'SMARCAL1', 'BRIP1', 'MRE11', 'HERC2', 'SP1', 'H2AFX', 'USP1', 'RPA1', 'ATM', 'MCM2']",0.8719080130566177,0,0,12
143,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.24668220807226507,1.399208645839485,1.958408506518703,"['MAPK9', 'CHUK', 'MAP3K8', 'PTPN6', 'RAF1', 'CALM1', 'MAP3K14', 'MALT1']",0.8719080130566177,0,0,8
144,Angiogenesis WP1539,0.2513533592247805,1.6867483581156,2.3292232581790593,"['CREBBP', 'ARNT', 'HIF1A', 'PTK2']",0.8719080130566177,0,0,4
145,Differentiation of white and brown adipocyte WP2895,0.2513533592247805,1.6867483581156,2.3292232581790593,"['PLAC8', 'CEBPA', 'PPARGC1A', 'SMAD5']",0.8719080130566177,0,0,4
146,IL-7 signaling pathway WP205,0.2513533592247805,1.6867483581156,2.3292232581790593,"['STAT5B', 'CDKN1B', 'CCND1', 'BAD']",0.8719080130566177,0,0,4
147,Neural Crest Cell Migration in Cancer WP4565,0.2528905388707963,1.483409238776838,2.0393888505905644,"['NTRK2', 'TIAM1', 'KIDINS220', 'PIK3R4', 'PIK3CB', 'PAK2']",0.8719080130566177,0,0,6
148,Melanoma WP4685,0.25378253249639193,1.3280731046121255,1.8211568330624206,"['RB1', 'GRM3', 'GRIN2A', 'CCND1', 'BAD', 'NF1', 'KRAS', 'PIK3CB', 'RAF1', 'CALM1']",0.8719080130566177,0,0,10
149,One-carbon metabolism WP241,0.2538211284999795,1.5585316626019678,2.1369424717141277,"['AHCYL2', 'DNMT1', 'MTRR', 'AHCY', 'MAT2B']",0.8719080130566177,0,0,5
150,Heme Biosynthesis WP561,0.2558494555687372,2.389023016256237,3.2566351201867,"['UROD', 'UROS']",0.8719080130566177,0,0,2
151,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.2558494555687372,2.389023016256237,3.2566351201867,"['TIFA', 'UBE2N']",0.8719080130566177,0,0,2
152,Macrophage markers WP4146,0.2558494555687372,2.389023016256237,3.2566351201867,"['CD74', 'CD83']",0.8719080130566177,0,0,2
153,ErbB signaling pathway WP673,0.2644006230887345,1.2600039359748099,1.6761704021228951,"['STAT5B', 'CDKN1B', 'BAD', 'CBLB', 'PIK3CB', 'NRG2', 'PTK2', 'MAPK9', 'CCND1', 'RPS6KB1', 'KRAS', 'RAF1', 'PAK2']",0.8839711271952108,0,0,13
154,Wnt Signaling Pathway WP363,0.2647073545349754,1.3658019139859334,1.815328824751645,"['MAPK9', 'GSK3A', 'CCND1', 'APC', 'DVL2', 'ARRB2', 'PI4K2A', 'LRP6']",0.8839711271952108,0,0,8
155,Regulation of Microtubule Cytoskeleton WP2038,0.26992858031251893,1.3941459610627085,1.8257705843331204,"['TIAM1', 'ROCK1', 'APC', 'CFL2', 'TPPP', 'CLASP1', 'MARK1']",0.8839711271952108,0,0,7
156,IL-2 signaling pathway WP49,0.27466489001584615,1.4338655055636187,1.8528460336377175,"['STAT5B', 'CISH', 'RPS6KB1', 'RPS6', 'FOXO3', 'RAF1']",0.8839711271952108,0,0,6
157,Biomarkers for pyrimidine metabolism disorders WP4584,0.27604817224747247,1.7919082125603865,2.306508218381852,"['RRM2B', 'DPYD', 'CKB']",0.8839711271952108,0,0,3
158,ERK Pathway in Huntington's Disease WP3853,0.27604817224747247,1.7919082125603865,2.306508218381852,"['NTRK2', 'RAF1', 'GRM1']",0.8839711271952108,0,0,3
159,Prolactin Signaling Pathway WP2037,0.27835353823286757,1.2723084384093113,1.6271085083389,"['MAPK9', 'STAT5B', 'CISH', 'RPS6KB1', 'RPS6', 'PTPN6', 'PIK3CB', 'RAF1', 'CTSD', 'YWHAG', 'PTK2']",0.8839711271952108,0,0,11
160,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2783742170984501,1.4934921018697613,1.9098612203916747,"['SMAD2', 'SEC16B', 'SMAD4', 'APAF1', 'RAF1']",0.8839711271952108,0,0,5
161,Sphingolipid pathway WP1422,0.2783742170984501,1.4934921018697613,1.9098612203916747,"['CERS5', 'CERK', 'SGMS1', 'SERINC1', 'PPP1CA']",0.8839711271952108,0,0,5
162,Constitutive Androstane Receptor Pathway WP2875,0.2798673066795648,1.592932710380753,2.028503741449226,"['PTPA', 'NCOA6', 'SP1', 'PPARGC1A']",0.8839711271952108,0,0,4
163,Nanoparticle triggered autophagic cell death WP2509,0.2798673066795648,1.592932710380753,2.028503741449226,"['VMP1', 'INSR', 'ATG10', 'AMBRA1']",0.8839711271952108,0,0,4
164,PKC-gamma calcium signaling pathway in ataxia WP4760,0.2798673066795648,1.592932710380753,2.028503741449226,"['CACNA1A', 'RYR3', 'GRM1', 'GRIA3']",0.8839711271952108,0,0,4
165,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.28310155369311507,1.3339489836139422,1.6833763846071594,"['CDKN1B', 'HSPA5', 'RPS6KB1', 'HDAC1', 'ANXA5', 'PAK2', 'TNFRSF21', 'PTK2']",0.8861953620637586,0,0,8
166,Glioblastoma signaling pathways WP2261,0.2857689258158972,1.2471784486213953,1.5621804874918683,"['RB1', 'PRKCI', 'CDKN1B', 'CCND1', 'NF1', 'EP300', 'ATM', 'KRAS', 'PIK3CB', 'RAF1', 'FOXO3', 'PIK3C2B']",0.8861953620637586,0,0,12
167,Oncostatin M Signaling Pathway WP2374,0.2936227991294628,1.290610465116279,1.581590637867623,"['MAPK9', 'STAT5B', 'CDKN1B', 'PRKCE', 'RPS6', 'LIFR', 'KRAS', 'RAF1', 'HIF1A']",0.8861953620637586,0,0,9
168,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.29685595600957715,1.3875181422351233,1.6851522369146597,"['MAPK9', 'CHUK', 'HDAC1', 'TRAF3', 'RAF1', 'MAP3K14']",0.8861953620637586,0,0,6
169,Pyrimidine metabolism WP4022,0.3005389671734653,1.2292784362653357,1.477811318574854,"['POLA1', 'PNPT1', 'RRM2B', 'POLR2A', 'NME7', 'POLR2C', 'DPYD', 'CMPK1', 'CTPS1', 'POLR3H', 'TK1', 'ENPP3']",0.8861953620637586,0,0,12
170,Retinoblastoma gene in cancer WP2446,0.3005389671734653,1.2292784362653357,1.477811318574854,"['RB1', 'BARD1', 'POLA1', 'DNMT1', 'CDKN1B', 'CCND1', 'HDAC1', 'FAF1', 'MCM3', 'RPA1', 'RAF1', 'CDC25B']",0.8861953620637586,0,0,12
171,Genotoxicity pathway WP4286,0.3018124815276187,1.3035439137134053,1.5615796187426967,"['IKBIP', 'AMER1', 'RRM2B', 'EI24', 'CBLB', 'LRRFIP2', 'SMAD5', 'PHLDA3']",0.8861953620637586,0,0,8
172,Sleep regulation WP3591,0.3033691550036424,1.4336557059961315,1.7100715247795375,"['CACNA1I', 'NLGN1', 'GRIN2A', 'AHCY', 'NPY2R']",0.8861953620637586,0,0,5
173,Cytosine methylation WP3585,0.30395593336862325,2.047596054356074,2.4384259225551297,"['DNMT1', 'TET2']",0.8861953620637586,0,0,2
174,"Degradation pathway of sphingolipids, including diseases WP4153",0.30395593336862325,2.047596054356074,2.4384259225551297,"['GLB1', 'NEU1']",0.8861953620637586,0,0,2
175,Leptin and adiponectin WP3934,0.30395593336862325,2.047596054356074,2.4384259225551297,"['PRKAA1', 'ADIPOR1']",0.8861953620637586,0,0,2
176,EPO Receptor Signaling WP581,0.3088414215322632,1.508992393986416,1.7729564085925327,"['STAT5B', 'CISH', 'RASA1', 'RAF1']",0.8861953620637586,0,0,4
177,miRNA regulation of p53 pathway in prostate cancer WP3982,0.3088414215322632,1.508992393986416,1.7729564085925327,"['APAF1', 'EI24', 'SHISA5', 'ATM']",0.8861953620637586,0,0,4
178,TLR4 Signaling and Tolerance WP3851,0.3088414215322632,1.508992393986416,1.7729564085925327,"['TBK1', 'CHUK', 'TRAF3', 'IKBKE']",0.8861953620637586,0,0,4
179,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.31136593802240164,1.6539576365663322,1.929815291279621,"['MADD', 'MYRIP', 'SYTL3']",0.8861953620637586,0,0,3
180,MAPK pathway in congenital thyroid cancer WP4928,0.31136593802240164,1.6539576365663322,1.929815291279621,"['KSR1', 'KRAS', 'RAF1']",0.8861953620637586,0,0,3
181,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.31136593802240164,1.6539576365663322,1.929815291279621,"['PRKAA1', 'SCD', 'PPARGC1A']",0.8861953620637586,0,0,3
182,Transcription co-factors SKI and SKIL protein partners WP4533,0.31136593802240164,1.6539576365663322,1.929815291279621,"['LATS1', 'HDAC1', 'NF1']",0.8861953620637586,0,0,3
183,Small cell lung cancer WP4658,0.3207335022750338,1.1950647249190938,1.358961532020398,"['RB1', 'CDKN1B', 'APAF1', 'CHUK', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3CB', 'FHIT', 'PTK2', 'CCND1', 'TRAF3', 'RARB']",0.9030862158001649,0,0,13
184,Modulators of TCR signaling and T cell activation WP5072,0.32078738167418985,1.274490180252892,1.4490656873704129,"['CDKN1B', 'CHUK', 'TNFAIP3', 'CBLB', 'MAP3K8', 'PTPN6', 'MAP3K14', 'MALT1']",0.9030862158001649,0,0,8
185,Apoptosis Modulation and Signaling WP1772,0.325265811532797,1.2133402969484444,1.362717714069279,"['PIDD1', 'ENDOG', 'APAF1', 'TRAF3', 'BAD', 'BNIP3', 'TOLLIP', 'PEA15', 'MADD', 'HTRA2', 'MAP3K14']",0.905614713105174,0,0,11
186,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.3286786989648122,1.3784221098050886,1.5337352755737745,"['TBK1', 'CHUK', 'DDX58', 'TRAF3', 'IKBKE']",0.905614713105174,0,0,5
187,Neovascularisation processes WP4331,0.3286786989648122,1.3784221098050886,1.5337352755737745,"['SMAD2', 'MAPK9', 'TGFB2', 'HIF1A', 'SMAD5']",0.905614713105174,0,0,5
188,The influence of laminopathies on Wnt signaling WP4844,0.3286786989648122,1.3784221098050886,1.5337352755737745,"['CEBPA', 'CCND1', 'APC', 'DICER1', 'EMD']",0.905614713105174,0,0,5
189,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.33105075560791564,1.2866433340779904,1.42236307290627,"['EIF4A2', 'RPTOR', 'MAPK9', 'RPS6KB1', 'RPS6', 'PIK3CB', 'EIF4G1']",0.9073242931476206,0,0,7
190,Sphingolipid Metabolism (integrated pathway) WP4726,0.338082149384902,1.4334461092315127,1.5545240951031298,"['CERS5', 'CERK', 'SGMS1', 'DEGS1']",0.9090074561199576,0,0,4
191,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.338082149384902,1.4334461092315127,1.5545240951031298,"['GSK3A', 'RASA1', 'PTPN6', 'CALM1']",0.9090074561199576,0,0,4
192,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.338082149384902,1.4334461092315127,1.5545240951031298,"['TBK1', 'DDX58', 'TRAF3', 'IKBKE']",0.9090074561199576,0,0,4
193,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3399735075435599,1.24669965259501,1.345048775410486,"['LATS1', 'RAD52', 'MRE11', 'KAT5', 'APAF1', 'CDK5', 'H2AFX', 'ATM']",0.9090074561199576,0,0,8
194,Glycogen Synthesis and Degradation WP500,0.3421281691206157,1.3032502089105862,1.397826879279039,"['PTPA', 'GSK3A', 'PPP2R1A', 'PHKB', 'CALM1', 'PHKA2']",0.9090074561199576,0,0,6
195,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.34678696453266755,1.5357142857142858,1.6263899561893687,"['PRKAA1', 'MKNK1', 'RAF1']",0.9090074561199576,0,0,3
196,BMP Signaling Pathway in Eyelid Development WP3927,0.34678696453266755,1.5357142857142858,1.6263899561893687,"['MAPK9', 'SMAD4', 'SMAD5']",0.9090074561199576,0,0,3
197,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.35144874443420937,1.7915258329309511,1.8733831526060671,"['SMAD4', 'BMPR1A']",0.9090074561199576,0,0,2
198,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.35144874443420937,1.7915258329309511,1.8733831526060671,"['AHCY', 'MAT2B']",0.9090074561199576,0,0,2
199,Valproic acid pathway WP3871,0.35144874443420937,1.7915258329309511,1.8733831526060671,"['HADHB', 'HDAC1']",0.9090074561199576,0,0,2
200,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.35189454234389866,1.254392545982575,1.3101173591774309,"['MAPK9', 'MAP3K3', 'CHUK', 'MKNK1', 'TOLLIP', 'MAP3K8', 'MAP3K14']",0.9090074561199576,0,0,7
201,Selenium Micronutrient Network WP15,0.3527229704249256,1.1947810631766036,1.245048270198644,"['PRDX3', 'SELENOS', 'RFK', 'PRDX1', 'INSR', 'SELENOP', 'PNPO', 'HBA1', 'SELENOT', 'SELENOK']",0.9090074561199576,0,0,10
202,Common Pathways Underlying Drug Addiction WP2636,0.3650336867987207,1.2648339451891062,1.2746561865474877,"['GRIN2A', 'RAF1', 'CALM1', 'GRM1', 'GRIA3', 'PPP1CA']",0.9093247829232551,0,0,6
203,DNA Replication WP466,0.3650336867987207,1.2648339451891062,1.2746561865474877,"['POLA1', 'UBC', 'ORC2', 'RPA1', 'MCM3', 'MCM2']",0.9093247829232551,0,0,6
204,NO/cGMP/PKG mediated Neuroprotection WP4008,0.3650336867987207,1.2648339451891062,1.2746561865474877,"['GRIN2A', 'BAD', 'AKAP9', 'CALM1', 'GRIN2B', 'PPID']",0.9093247829232551,0,0,6
205,Cell migration and invasion through p75NTR WP4561,0.36740841041389843,1.3650947087389813,1.366843688220549,"['NTRK2', 'TIAM1', 'EFNA3', 'KIDINS220']",0.9093247829232551,0,0,4
206,IL-4 signaling pathway WP395,0.37286329432454934,1.2237149670625458,1.2072479605423863,"['CEBPA', 'STAT5B', 'CHUK', 'RPS6KB1', 'BAD', 'EP300', 'PTPN6']",0.9093247829232551,0,0,7
207,Phosphoinositides metabolism WP4971,0.37286329432454934,1.2237149670625458,1.2072479605423863,"['PIKFYVE', 'PIP4P1', 'PIK3R4', 'PIK3CB', 'PIP4K2C', 'SBF2', 'PIK3C2B']",0.9093247829232551,0,0,7
208,Amino Acid metabolism WP3925,0.37368434134718836,1.159575226792948,1.1414207373489424,"['ACLY', 'LDHA', 'PKM', 'OAT', 'PDHA1', 'AUH', 'MDH1', 'MCCC1', 'GOT2', 'ALDH18A1', 'GLUL']",0.9093247829232551,0,0,11
209,Senescence and Autophagy in Cancer WP615,0.3768819978195721,1.1469383794274624,1.119209014998289,"['RB1', 'RSL1D1', 'SMAD4', 'SPARC', 'CDKN1B', 'KMT2A', 'AKT1S1', 'ATG10', 'HMGA1', 'AMBRA1', 'RAF1', 'CDC25B']",0.9093247829232551,0,0,12
210,Kit receptor signaling pathway WP304,0.3787709426250747,1.1945924132364811,1.1597385425438524,"['STAT5B', 'RPS6KB1', 'BAD', 'RPS6', 'EP300', 'PTPN6', 'RAF1', 'FOXO3']",0.9093247829232551,0,0,8
211,Amyotrophic lateral sclerosis (ALS) WP2447,0.3797560099165788,1.2797906880353689,1.2391270175601299,"['PPP3CC', 'APAF1', 'BAD', 'NEFM', 'NEFH']",0.9093247829232551,0,0,5
212,BDNF-TrkB Signaling WP3676,0.3797560099165788,1.2797906880353689,1.2391270175601299,"['NTRK2', 'EEF2K', 'RPS6KB1', 'MKNK1', 'KRAS']",0.9093247829232551,0,0,5
213,Nuclear receptors WP170,0.3797560099165788,1.2797906880353689,1.2391270175601299,"['THRB', 'HNF4A', 'NR1H2', 'RARB', 'NR2F6']",0.9093247829232551,0,0,5
214,Nanomaterial induced apoptosis WP2507,0.3820152241684574,1.4332367149758454,1.3791962628219896,"['ENDOG', 'APAF1', 'HTRA2']",0.9093247829232551,0,0,3
215,Nicotine Activity on Dopaminergic Neurons WP1602,0.3820152241684574,1.4332367149758454,1.3791962628219896,"['CDK5', 'PPP1R1B', 'PPP1CA']",0.9093247829232551,0,0,3
216,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.3820152241684574,1.4332367149758454,1.3791962628219896,"['ANXA5', 'NRF1', 'PKD1']",0.9093247829232551,0,0,3
217,Transcription factor regulation in adipogenesis WP3599,0.3820152241684574,1.4332367149758454,1.3791962628219896,"['CEBPA', 'INSR', 'PPARGC1A']",0.9093247829232551,0,0,3
218,Ectoderm Differentiation WP2858,0.38695185833182366,1.1079014856738592,1.0519025948497838,"['SMAD4', 'NLGN1', 'KCNK10', 'ARHGDIG', 'LDB2', 'CELSR2', 'WDR44', 'CDH6', 'TRPM2', 'PPFIBP2', 'GLB1', 'NARS2', 'DMD', 'TRIM33', 'CDON', 'ASTN1', 'BMPR1A']",0.9093247829232551,0,0,17
219,Copper homeostasis WP3286,0.3938934698560068,1.1944982252339464,1.1128838799488128,"['PRNP', 'CCND1', 'APC', 'SCO2', 'SP1', 'FOXO3', 'MT3']",0.9093247829232551,0,0,7
220,Signal transduction through IL1R WP4496,0.3966530990219869,1.3029570719275891,1.2048355264214372,"['TGFB2', 'CHUK', 'TOLLIP', 'MAP3K14']",0.9093247829232551,0,0,4
221,Neuroinflammation WP4919,0.39775648203114816,1.592360105155856,1.4680211681769821,"['CHUK', 'ASCC1']",0.9093247829232551,0,0,2
222,Osteopontin Signaling WP1434,0.39775648203114816,1.592360105155856,1.4680211681769821,"['CHUK', 'MAP3K14']",0.9093247829232551,0,0,2
223,Sulfation Biotransformation Reaction WP692,0.39775648203114816,1.592360105155856,1.4680211681769821,"['PAPSS2', 'PAPSS1']",0.9093247829232551,0,0,2
224,Transcriptional cascade regulating adipogenesis WP4211,0.39775648203114816,1.592360105155856,1.4680211681769821,"['CEBPA', 'KLF15']",0.9093247829232551,0,0,2
225,Vitamin B12 Disorders WP4271,0.39775648203114816,1.592360105155856,1.4680211681769821,"['MTRR', 'MMADHC']",0.9093247829232551,0,0,2
226,Notch Signaling Pathway Netpath WP61,0.3982803590811346,1.1701339131294164,1.0772242295098173,"['NOTCH2', 'APH1A', 'SPEN', 'ITCH', 'CCND1', 'HDAC1', 'EP300', 'HIF1A']",0.9093247829232551,0,0,8
227,Myometrial relaxation and contraction pathways WP289,0.40078744993337223,1.0934801435110726,0.9997951849277361,"['ATF1', 'RGS14', 'GSTO1', 'PRKCE', 'ARRB2', 'RYR3', 'ADCY5', 'CNN1', 'CREB3', 'CACNB3', 'CALD1', 'SP1', 'PRKAR2A', 'GNB2', 'IGFBP6', 'CALM1', 'RGS6', 'YWHAG']",0.9093247829232551,0,0,18
228,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.4071279972061351,2.3883526383526386,2.146239727207453,['TRAF3'],0.9093247829232551,0,0,1
229,Gastric acid production WP2596,0.4071279972061351,2.3883526383526386,2.146239727207453,['CCK'],0.9093247829232551,0,0,1
230,Nanomaterial-induced inflammasome activation WP3890,0.4071279972061351,2.3883526383526386,2.146239727207453,['CTSB'],0.9093247829232551,0,0,1
231,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.4071279972061351,2.3883526383526386,2.146239727207453,['CHRM1'],0.9093247829232551,0,0,1
232,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.41339573370111715,1.0842176286573024,0.9577435900303675,"['NOTCH2', 'SMAD2', 'TGFB2', 'SMAD4', 'SPARC', 'NUBPL', 'EIF5A2', 'FZD6', 'FZD9', 'PIK3CB', 'HIF1A', 'PKD1', 'LRP6', 'CLDN4', 'CDH2', 'MMP15', 'KRAS', 'RAF1']",0.9093247829232551,0,0,18
233,Mitochondrial complex I assembly model OXPHOS system WP4324,0.41492376146644283,1.1666404016299332,1.0262474591121509,"['NDUFB9', 'NUBPL', 'NDUFAF7', 'NDUFS4', 'NDUFS3', 'NDUFAF3', 'TMEM70']",0.9093247829232551,0,0,7
234,Ebstein-Barr virus LMP1 signaling WP262,0.4167938567042454,1.3435688405797102,1.1758424464241837,"['MAP3K3', 'CHUK', 'MAP3K14']",0.9093247829232551,0,0,3
235,Nucleotide metabolism WP404,0.4167938567042454,1.3435688405797102,1.1758424464241837,"['PRPS1', 'POLA1', 'RRM2B']",0.9093247829232551,0,0,3
236,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4167938567042454,1.3435688405797102,1.1758424464241837,"['TBK1', 'CHUK', 'IKBKE']",0.9093247829232551,0,0,3
237,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.41779787323500917,1.1466537530266343,1.000750686091495,"['CDKN1B', 'APC', 'FZD6', 'FZD9', 'NEFM', 'RAF1', 'NEFH', 'PTK2']",0.9093247829232551,0,0,8
238,"GPCRs, Other WP117",0.41779787323500917,1.1466537530266343,1.000750686091495,"['CHRM3', 'GPR176', 'ADGRV1', 'OR2M4', 'CELSR2', 'GRM1', 'GPR135', 'ADGRL3']",0.9093247829232551,0,0,8
239,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4228016206563151,1.1103536836928458,0.9558504023270804,"['CCND1', 'RPS6KB1', 'BAD', 'RPS6', 'NF1', 'RRAS2', 'KRAS', 'PIK3CB', 'NRG2', 'RAF1', 'FOXO3']",0.9111321307722237,0,0,11
240,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4228016206563151,1.1103536836928458,0.9558504023270804,"['RPTOR', 'CREB3', 'RPS6KA6', 'THRB', 'RPS6KB1', 'BAD', 'RPS6', 'ZNF516', 'AKT1S1', 'RAF1', 'PPARGC1A']",0.9111321307722237,0,0,11
241,Gastric Cancer Network 2 WP2363,0.4256640456503438,1.2462227078824049,1.0644048827544024,"['PLAC8', 'UBE2T', 'CACYBP', 'LBR']",0.9111321307722237,0,0,4
242,Nanoparticle-mediated activation of receptor signaling WP2643,0.4256640456503438,1.2462227078824049,1.0644048827544024,"['MAPK9', 'KRAS', 'RAF1', 'PTK2']",0.9111321307722237,0,0,4
243,Interleukin-11 Signaling Pathway WP2332,0.43383683755246855,1.1620444827991998,0.9704079689828463,"['ATF1', 'PTPA', 'CHUK', 'RPS6KB1', 'RPS6', 'RAF1']",0.9166347102824808,0,0,6
244,Netrin-UNC5B signaling pathway WP4747,0.43383683755246855,1.1620444827991998,0.9704079689828463,"['PTPA', 'ARHGEF12', 'RAF1', 'RLF', 'PTK2', 'PPP1CA']",0.9166347102824808,0,0,6
245,Phosphodiesterases in neuronal function WP4222,0.4358954694271895,1.1400488427351931,0.9466427639759609,"['GRIN2A', 'PDE1C', 'PDE1A', 'PPP1R1B', 'PDE8A', 'GRIN2B', 'ADCY5']",0.9166347102824808,0,0,7
246,Cancer immunotherapy by CTLA4 blockade WP4582,0.4424568248259457,1.4330275229357798,1.1685083978561166,"['PTPN6', 'PIK3CB']",0.9166347102824808,0,0,2
247,Genes targeted by miRNAs in adipocytes WP1992,0.4424568248259457,1.4330275229357798,1.1685083978561166,"['ERG', 'KCNJ2']",0.9166347102824808,0,0,2
248,Iron metabolism in placenta WP2007,0.4424568248259457,1.4330275229357798,1.1685083978561166,"['TFRC', 'ACO1']",0.9166347102824808,0,0,2
249,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4424568248259457,1.4330275229357798,1.1685083978561166,"['RYR3', 'PTK2']",0.9166347102824808,0,0,2
250,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.4509039087050514,1.2644501278772378,1.0071358228129197,"['EGLN2', 'CCND1', 'CHUK']",0.9166347102824808,0,0,3
251,Purine metabolism and related disorders WP4224,0.4509039087050514,1.2644501278772378,1.0071358228129197,"['PRPS1', 'RRM2B', 'AOX1']",0.9166347102824808,0,0,3
252,"Relationship between inflammation, COX-2 and EGFR WP4483",0.4509039087050514,1.2644501278772378,1.0071358228129197,"['PTGES2', 'KRAS', 'PIK3CB']",0.9166347102824808,0,0,3
253,Aryl Hydrocarbon Receptor Pathway WP2873,0.4543045207787891,1.1942162075076526,0.9422217259170399,"['CDKN1B', 'AIP', 'EP300', 'ARNT']",0.9166347102824808,0,0,4
254,Endothelin Pathways WP2197,0.4543045207787891,1.1942162075076526,0.9422217259170399,"['CNN1', 'NPY1R', 'RAF1', 'CALM1']",0.9166347102824808,0,0,4
255,Glycerophospholipid Biosynthetic Pathway WP2533,0.4543045207787891,1.1942162075076526,0.9422217259170399,"['PCYT2', 'PTPMT1', 'PIK3CB', 'PI4K2A']",0.9166347102824808,0,0,4
256,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.45586341858466833,1.1557059961315281,0.9078787541604527,"['RPTOR', 'SMAD2', 'RPS6KB1', 'AKT1S1', 'PPARGC1A']",0.9166347102824808,0,0,5
257,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.45586341858466833,1.1557059961315281,0.9078787541604527,"['PRKCE', 'KRAS', 'PIK3CB', 'ARRB2', 'RAF1']",0.9166347102824808,0,0,5
258,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.45654779006347496,1.1313879764723855,0.887078202448228,"['SCD', 'NR1H2', 'ELOVL3', 'DHCR24', 'ACSL3', 'LBR']",0.9166347102824808,0,0,6
259,Chemokine signaling pathway WP3929,0.4660178869768878,1.051856939606535,0.8031256560390433,"['STAT5B', 'CHUK', 'ROCK1', 'GNAI3', 'ARRB2', 'PIK3CB', 'FOXO3', 'RASGRP2', 'PTK2', 'CX3CL1', 'ADCY5', 'TIAM2', 'TIAM1', 'GNB2', 'KRAS', 'RAF1']",0.9241131657417638,0,0,16
260,Thermogenesis WP4321,0.46938674282905996,1.0585447925860547,0.8006073186308649,"['PRKAA1', 'RPS6', 'ACSL3', 'ADCY5', 'RPTOR', 'CREB3', 'RPS6KA6', 'RPS6KB1', 'AKT1S1', 'ZNF516', 'KRAS', 'PPARGC1A', 'PRKG1']",0.9241131657417638,0,0,13
261,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.47314378617719693,1.069446755558128,0.8003268416558252,"['CISH', 'CHUK', 'ROCK1', 'PIK3CB', 'RAF1', 'CALM1', 'IKBKE', 'MAP3K14', 'PRKG1', 'LRP6']",0.9241131657417638,0,0,10
262,Acetylcholine Synthesis WP528,0.47977379036712486,1.7911438223938223,1.31548866520923,['PDHA1'],0.9241131657417638,0,0,1
263,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.47977379036712486,1.7911438223938223,1.31548866520923,['SLIT2'],0.9241131657417638,0,0,1
264,Hedgehog Signaling Pathway WP4249,0.480708324092711,1.1195146276595744,0.8200384055284643,"['CCND1', 'CUL3', 'FBXL17', 'ARRB2', 'CDON']",0.9241131657417638,0,0,5
265,Oxidative Damage WP3941,0.480708324092711,1.1195146276595744,0.8200384055284643,"['C5', 'CDKN1B', 'APAF1', 'BAD', 'TRAF3']",0.9241131657417638,0,0,5
266,Vitamin D-sensitive calcium signaling in depression WP4698,0.480708324092711,1.1195146276595744,0.8200384055284643,"['GRIN2A', 'CHRM1', 'KCNQ3', 'CACNA1C', 'GRIN2B']",0.9241131657417638,0,0,5
267,Trans-sulfuration and one-carbon metabolism WP2525,0.48245335705838965,1.1463702271628806,0.8355560507382611,"['AHCYL2', 'DNMT1', 'AHCY', 'MAT2B']",0.9241131657417638,0,0,4
268,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.48524861212694936,1.3026645011193538,0.941948776725155,"['CCK', 'RYR3']",0.9241131657417638,0,0,2
269,Ganglio Sphingolipid Metabolism WP1423,0.48524861212694936,1.3026645011193538,0.941948776725155,"['FUT1', 'ST6GALNAC6']",0.9241131657417638,0,0,2
270,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.48524861212694936,1.3026645011193538,0.941948776725155,"['RB1', 'CCND1']",0.9241131657417638,0,0,2
271,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.48524861212694936,1.3026645011193538,0.941948776725155,"['MAD1L1', 'MAD2L1']",0.9241131657417638,0,0,2
272,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.48524861212694936,1.3026645011193538,0.941948776725155,"['TIFA', 'UBE2N']",0.9241131657417638,0,0,2
273,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.4901608663472842,1.0536483134213452,0.7512740516723281,"['HNRNPK', 'CCND1', 'APC', 'CHD8', 'SERPINF1', 'CSNK2B', 'FZD6', 'DVL2', 'FZD9', 'LRP6']",0.9264265917096351,0,0,10
274,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.49247508495423525,1.0570911170415556,0.7487496981038952,"['CCND1', 'APC', 'CHD8', 'SERPINF1', 'CSNK2B', 'FZD6', 'DVL2', 'FZD9', 'LRP6']",0.9264265917096351,0,0,9
275,Ebola Virus Pathway on Host WP4217,0.4967964940248445,1.0340721899831267,0.7234108511841504,"['VPS18', 'CREBBP', 'TSG101', 'DDX58', 'ACTN1', 'CLTC', 'VPS4A', 'PIK3CB', 'TIAM1', 'TBK1', 'VPS11', 'EP300', 'IKBKE', 'CTSB']",0.9264265917096351,0,0,14
276,Osteoblast differentiation WP4787,0.49905091050260497,1.034881337648328,0.7192913381668526,"['NOTCH2', 'PRKCI', 'SMAD4', 'PRKCE', 'FZD6', 'PIK3R4', 'FZD9', 'PIK3CB', 'SMAD5', 'PIK3C2B', 'LRP6', 'MAPK9', 'BMPR1A']",0.9264265917096351,0,0,13
277,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5012297233973712,1.0746734397677793,0.7422670076159574,"['PPP1R3F', 'PPP1R13B', 'HSPA5', 'PPP1R1B', 'PPP1R12B', 'PPP1CA']",0.9264265917096351,0,0,6
278,Proximal tubule transport WP4917,0.5012297233973712,1.0746734397677793,0.7422670076159574,"['ATP6V1A', 'ATP6V0B', 'ATP1A1', 'ATP6V0C', 'ATP6V1C1', 'AQP1']",0.9264265917096351,0,0,6
279,Cytoplasmic Ribosomal Proteins WP477,0.5041320038552798,1.036953136964623,0.7102269694100675,"['RPL4', 'RPS6KA6', 'RPS16', 'RPS6KB1', 'RPL27A', 'RPLP0', 'RPS6', 'RPL36', 'RPL14', 'RPL23A', 'RPS11']",0.9264265917096351,0,0,11
280,ATM Signaling Pathway WP2516,0.505153003208815,1.0855166754586483,0.7412927365828184,"['PIDD1', 'MAPK9', 'MRE11', 'H2AFX', 'ATM']",0.9264265917096351,0,0,5
281,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5100047592588766,1.1022047068446295,0.7421532503412834,"['COPS6', 'CHUK', 'NLRP1', 'AAMP']",0.9264265917096351,0,0,4
282,Prion disease pathway WP3995,0.5100047592588766,1.1022047068446295,0.7421532503412834,"['PRNP', 'HSPA5', 'EP300', 'PTK2']",0.9264265917096351,0,0,4
283,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5139289256900803,1.042060312568787,0.6936686008395402,"['MAPK9', 'STAT5B', 'CHUK', 'TNIP1', 'BAD', 'RASA1', 'KRAS', 'PTK2']",0.9264265917096351,0,0,8
284,Estrogen signaling pathway WP712,0.5164194089515908,1.1311975591151793,0.7475361104510814,"['MAPK9', 'CHUK', 'SP1']",0.9264265917096351,0,0,3
285,Fatty Acid Biosynthesis WP357,0.5164194089515908,1.1311975591151793,0.7475361104510814,"['ACLY', 'SCD', 'ACSL3']",0.9264265917096351,0,0,3
286,NRF2-ARE regulation WP4357,0.5164194089515908,1.1311975591151793,0.7475361104510814,"['CUL3', 'INSR', 'PGAM5']",0.9264265917096351,0,0,3
287,Exercise-induced Circadian Regulation WP410,0.5230836417159874,1.0483910934900351,0.6793720021664631,"['PER1', 'TUBB3', 'GSTP1', 'KLF9', 'CRY1', 'ARNTL']",0.9264265917096351,0,0,6
288,Fatty acid transporters WP5061,0.5259285192662361,1.1940286496056656,0.7672708346189046,"['ACSL3', 'CD36']",0.9264265917096351,0,0,2
289,Galanin receptor pathway WP4970,0.5259285192662361,1.1940286496056656,0.7672708346189046,"['CDKN1B', 'PPARGC1A']",0.9264265917096351,0,0,2
290,ID signaling pathway WP53,0.5259285192662361,1.1940286496056656,0.7672708346189046,"['RB1', 'RBL1']",0.9264265917096351,0,0,2
291,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5259285192662361,1.1940286496056656,0.7672708346189046,"['CLDN4', 'CCND1']",0.9264265917096351,0,0,2
292,Riboflavin and CoQ disorders WP5037,0.5259285192662361,1.1940286496056656,0.7672708346189046,"['RFK', 'PDSS2']",0.9264265917096351,0,0,2
293,PDGF Pathway WP2526,0.5291272312880394,1.0535186027989532,0.6705923648143087,"['TIAM1', 'CHUK', 'RASA1', 'ARFIP2', 'RAF1']",0.9264265917096351,0,0,5
294,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5291272312880394,1.0535186027989532,0.6705923648143087,"['MAPK9', 'STAT5B', 'CISH', 'RPS6', 'PI4K2A']",0.9264265917096351,0,0,5
295,22q11.2 copy number variation syndrome WP4657,0.5319133887581338,1.0113194622827297,0.6384202950730105,"['PRKN', 'OAT', 'POLR2A', 'THAP7', 'CUL3', 'DGCR6L', 'DROSHA', 'SHOC2', 'RAF1', 'RTN4', 'MALT1', 'ARNTL']",0.9264265917096351,0,0,12
296,Insulin Signaling WP481,0.5357542108260509,1.0007267025602842,0.6245333053522512,"['MAP3K3', 'PRKCI', 'RAB4A', 'GSK3A', 'PRKAA1', 'INSR', 'PIK3R4', 'CBLB', 'PIK3CB', 'FOXO3', 'MAPK9', 'RPS6KA6', 'RPS6KB1', 'RHOJ', 'MAP3K8', 'STX4', 'RAF1', 'MAP3K14', 'MAP4K4']",0.9264265917096351,0,0,19
297,FOXP3 in COVID-19 WP5063,0.5435218964590856,1.4328185328185328,0.8735683760494245,['STAT5B'],0.9264265917096351,0,0,1
298,FTO Obesity Variant Mechanism WP3407,0.5435218964590856,1.4328185328185328,0.8735683760494245,['PPARGC1A'],0.9264265917096351,0,0,1
299,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.5435218964590856,1.4328185328185328,0.8735683760494245,['HIF1A'],0.9264265917096351,0,0,1
300,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.5435218964590856,1.4328185328185328,0.8735683760494245,['PRKAA1'],0.9264265917096351,0,0,1
301,Folate Metabolism WP176,0.5445436800553355,1.0233602875112309,0.6220056683984513,"['SLC46A1', 'MTRR', 'AHCY', 'RFK', 'INSR', 'HBA1']",0.9264265917096351,0,0,6
302,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.54755608891175,1.0745652173913043,0.6472002899342604,"['RPS6KB1', 'RPS6', 'RAF1']",0.9264265917096351,0,0,3
303,Sphingolipid Metabolism (general overview) WP4725,0.54755608891175,1.0745652173913043,0.6472002899342604,"['CERK', 'SGMS1', 'DEGS1']",0.9264265917096351,0,0,3
304,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5509560761403771,1.00536085977656,0.5992957991597858,"['ACLY', 'GSK3A', 'PRKAA1', 'SEC24A', 'MDH1', 'SP1', 'SCD', 'NR1H2']",0.9264265917096351,0,0,8
305,Nephrotic syndrome WP4758,0.5525691531432237,1.0233489914340979,0.6070267668012939,"['SMARCAL1', 'PTPRO', 'PDSS2', 'GPC5', 'ARHGAP24']",0.9264265917096351,0,0,5
306,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.5565799631377096,0.9867101969746436,0.5781573431648842,"['PRKAA1', 'CDKN1B', 'PHLPP1', 'CHRM1', 'CAB39L', 'COL11A1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3R4', 'PIK3CB', 'FOXO3', 'HIF1A', 'PIK3C2B', 'RPTOR', 'PPP2R1A', 'PELO', 'PPARGC1A', 'BAD', 'INSR', 'RPS6', 'VEGFD', 'PTK2', 'CREB3', 'EFNA3', 'RPS6KB1', 'GNB2', 'AKT1S1', 'KRAS', 'RAF1', 'ITGA9']",0.9264265917096351,0,0,31
307,Mitochondrial CIV Assembly WP4922,0.5629661099636618,1.023337706276324,0.5879441969688846,"['COX8A', 'SURF1', 'SCO2', 'COX5A']",0.9264265917096351,0,0,4
308,Neural Crest Cell Migration during Development WP4564,0.5629661099636618,1.023337706276324,0.5879441969688846,"['TIAM1', 'PIK3R4', 'PIK3CB', 'PAK2']",0.9264265917096351,0,0,4
309,Mitochondrial complex III assembly WP4921,0.5643716249547478,1.1021060060171601,0.6304512930724625,"['UQCC3', 'CYC1']",0.9264265917096351,0,0,2
310,Overview of nanoparticle effects WP3287,0.5643716249547478,1.1021060060171601,0.6304512930724625,"['LAMA3', 'PTK2']",0.9264265917096351,0,0,2
311,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5643716249547478,1.1021060060171601,0.6304512930724625,"['APC', 'DVL2']",0.9264265917096351,0,0,2
312,Adipogenesis WP236,0.5711612552252603,0.9800817577925396,0.5489278179374473,"['RB1', 'STAT5B', 'CEBPA', 'HMGA1', 'LIFR', 'MIF', 'HIF1A', 'KLF15', 'BSCL2', 'RBL1', 'SP1', 'SCD', 'PPARGC1A']",0.9264265917096351,0,0,13
313,IL-6 signaling pathway WP364,0.5754250954289364,0.9948554695895121,0.5498031096726468,"['CREBBP', 'RPS6KB1', 'HDAC1', 'BAD', 'NR2F6']",0.9264265917096351,0,0,5
314,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.5754250954289364,0.9948554695895121,0.5498031096726468,"['LATS1', 'MAPK9', 'SGMS1', 'PAK2', 'MAP4K4']",0.9264265917096351,0,0,5
315,Wnt signaling WP428,0.5763498908830009,0.976644170967315,0.538170348978492,"['INVS', 'MAPK9', 'PPP3CC', 'CCND1', 'APC', 'SERPINF1', 'CHD8', 'CSNK2B', 'FZD6', 'DVL2', 'FZD9', 'LRP6']",0.9264265917096351,0,0,12
316,Canonical and non-canonical Notch signaling WP3845,0.5774809179733938,1.0233264320220843,0.5618879540886565,"['NOTCH2', 'CHUK', 'DNER']",0.9264265917096351,0,0,3
317,Physiological and pathological hypertrophy of the heart WP1528,0.5774809179733938,1.0233264320220843,0.5618879540886565,"['PRKCE', 'LIFR', 'CALM1']",0.9264265917096351,0,0,3
318,T-cell receptor (TCR) signaling pathway WP69,0.5792407504212203,0.9766781183932347,0.5333024717694551,"['MAPK9', 'CD83', 'CHUK', 'CBLB', 'MAP3K8', 'OPRM1', 'RAF1', 'MAP3K14', 'MALT1']",0.9264265917096351,0,0,9
319,Breast cancer pathway WP4262,0.5834231780204951,0.971037301319183,0.5232361603638523,"['RB1', 'NOTCH2', 'MRE11', 'NCOA3', 'FZD6', 'FZD9', 'LRP6', 'CCND1', 'RPS6KB1', 'APC', 'SP1', 'CSNK2B', 'DVL2', 'ATM', 'KRAS', 'RAF1']",0.9264265917096351,0,0,16
320,Melatonin metabolism and effects WP3298,0.5882364521318761,0.9879835336077732,0.5242500295501472,"['PER1', 'CRY1', 'CALM1', 'ARNTL']",0.9264265917096351,0,0,4
321,Nonalcoholic fatty liver disease WP4396,0.5958687566233789,0.962811959980881,0.4984812991064294,"['COX8A', 'CEBPA', 'NDUFB9', 'GSK3A', 'PRKAA1', 'INSR', 'PIK3CB', 'ADIPOR1', 'COX5A', 'VMP1', 'MLXIPL', 'MAPK9', 'ITCH', 'NDUFS4', 'NDUFS3', 'CYC1']",0.9264265917096351,0,0,16
322,Integrin-mediated Cell Adhesion WP185,0.5970527183654865,0.9606881786567624,0.4954747975063161,"['GIT2', 'ROCK1', 'ITGA2B', 'SELENOP', 'CAPN2', 'RAC3', 'RAF1', 'ARHGEF7', 'PAK2', 'PTK2', 'ITGA9']",0.9264265917096351,0,0,11
323,Notch Signaling WP268,0.5976492932188221,0.9679021381149041,0.4982287515158378,"['NOTCH2', 'APH1A', 'CREBBP', 'HDAC1', 'DVL2']",0.9264265917096351,0,0,5
324,Dual hijack model of Vif in HIV infection WP3300,0.5994616448366717,1.1939350064350065,0.6109643437473006,['UBB'],0.9264265917096351,0,0,1
325,LDLRAD4 and what we know about it WP4904,0.5994616448366717,1.1939350064350065,0.6109643437473006,['SMAD2'],0.9264265917096351,0,0,1
326,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5994616448366717,1.1939350064350065,0.6109643437473006,['HIF1A'],0.9264265917096351,0,0,1
327,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.5994616448366717,1.1939350064350065,0.6109643437473006,['CHUK'],0.9264265917096351,0,0,1
328,Tgif disruption of Shh signaling WP3674,0.5994616448366717,1.1939350064350065,0.6109643437473006,['SMAD2'],0.9264265917096351,0,0,1
329,Glycosaminoglycan degradation WP4815,0.6005152681856809,1.023315168655584,0.5218571835538867,"['GLB1', 'ARSB']",0.9264265917096351,0,0,2
330,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.6005152681856809,1.023315168655584,0.5218571835538867,"['AEBP2', 'STK38']",0.9264265917096351,0,0,2
331,Ovarian infertility WP34,0.6061271484451736,0.9767457180500658,0.48902288232850927,"['CDKN1B', 'ATM', 'SYNE2']",0.9264265917096351,0,0,3
332,Photodynamic therapy-induced unfolded protein response WP3613,0.6061271484451736,0.9767457180500658,0.48902288232850927,"['HSPA5', 'UBE2E1', 'DNAJB9']",0.9264265917096351,0,0,3
333,Striated Muscle Contraction Pathway WP383,0.6061271484451736,0.9767457180500658,0.48902288232850927,"['MYBPC1', 'TNNT2', 'DMD']",0.9264265917096351,0,0,3
334,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6061346828594892,0.9549427511691663,0.4780950187707211,"['MAPK9', 'TBK1', 'CHUK', 'DDX58', 'TRAF3', 'IKBKE']",0.9264265917096351,0,0,6
335,Oxidative phosphorylation WP623,0.6061346828594892,0.9549427511691663,0.4780950187707211,"['NDUFB9', 'ATP6AP1', 'ATP6AP2', 'NDUFS4', 'NDUFS3', 'ATP5F1D']",0.9264265917096351,0,0,6
336,RANKL/RANK signaling pathway WP2018,0.6061346828594892,0.9549427511691663,0.4780950187707211,"['MAPK9', 'CHUK', 'TRAF3', 'CTSK', 'PAPSS2', 'PTK2']",0.9264265917096351,0,0,6
337,Pre-implantation embryo WP3527,0.6126284879238117,0.9549863057837925,0.4679400260356765,"['HMGA1', 'SOX11', 'ATP1A1', 'MTA3']",0.9264265917096351,0,0,4
338,p53 transcriptional gene network WP4963,0.6139201881197454,0.9458802900509599,0.4614858620439808,"['PIDD1', 'APAF1', 'RRM2B', 'CCNG1', 'ERCC5', 'ACAD11', 'CX3CL1']",0.9264265917096351,0,0,7
339,IL-3 signaling pathway WP286,0.6192035486101386,0.9423674030336964,0.4516966987416921,"['STAT5B', 'BAD', 'PTPN6', 'ENPP3', 'RAF1']",0.9264265917096351,0,0,5
340,Peptide GPCRs WP24,0.6192035486101386,0.9423674030336964,0.4516966987416921,"['NPY2R', 'NPY1R', 'OPRL1', 'OPRM1', 'SSTR3']",0.9264265917096351,0,0,5
341,Cardiac Hypertrophic Response WP2795,0.6256192606936603,0.9341200227172336,0.43811471694586684,"['CHUK', 'RAF1', 'CALM1', 'IKBKE', 'MAP3K14', 'PRKG1']",0.9264265917096351,0,0,6
342,7-oxo-C and 7beta-HC pathways WP5064,0.6334498288871248,0.9342155009451796,0.42653895567622774,"['ACOT9', 'DBP', 'ACOT11']",0.9264265917096351,0,0,3
343,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6334498288871248,0.9342155009451796,0.42653895567622774,"['CEBPA', 'CCND1', 'CHUK']",0.9264265917096351,0,0,3
344,White fat cell differentiation WP4149,0.6334498288871248,0.9342155009451796,0.42653895567622774,"['CEBPA', 'STAT5B', 'KLF15']",0.9264265917096351,0,0,3
345,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['CCND1', 'ROS1']",0.9264265917096351,0,0,2
346,GDNF/RET signaling axis WP4830,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['SOX11', 'SLIT2']",0.9264265917096351,0,0,2
347,Matrix Metalloproteinases WP129,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['MMP15', 'TCF20']",0.9264265917096351,0,0,2
348,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['ACTN1', 'PTK2']",0.9264265917096351,0,0,2
349,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['EIF1AX', 'EIF3G']",0.9264265917096351,0,0,2
350,Pyrimidine metabolism and related diseases WP4225,0.6343456807044233,0.9550297762755513,0.4346925328409108,"['RRM2B', 'DPYD']",0.9264265917096351,0,0,2
351,Bladder cancer WP2828,0.6361035050994414,0.9241179313678105,0.41806539359651756,"['RB1', 'CCND1', 'KRAS', 'RAF1']",0.9264265917096351,0,0,4
352,Oxysterols derived from cholesterol WP4545,0.6361035050994414,0.9241179313678105,0.41806539359651756,"['ACOT9', 'DBP', 'NR1H2', 'ACOT11']",0.9264265917096351,0,0,4
353,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.6361035050994414,0.9241179313678105,0.41806539359651756,"['ATF1', 'CREB3', 'CAMK1D', 'CALM1']",0.9264265917096351,0,0,4
354,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6400568352371007,0.9181421415463968,0.40967346410586464,"['TBK1', 'AP1G1', 'DDX58', 'TRAF3', 'EP300']",0.9264265917096351,0,0,5
355,IL-1 signaling pathway WP195,0.6445353395598521,0.9141833678164469,0.4015327616286156,"['MAPK9', 'MAP3K3', 'CHUK', 'TOLLIP', 'UBE2N', 'MAP3K14']",0.9264265917096351,0,0,6
356,Caloric restriction and aging WP4191,0.6485490567996429,1.023303916161059,0.44310863809940254,['PPARGC1A'],0.9264265917096351,0,0,1
357,Canonical NF-KB pathway WP4562,0.6485490567996429,1.023303916161059,0.44310863809940254,['CHUK'],0.9264265917096351,0,0,1
358,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.6485490567996429,1.023303916161059,0.44310863809940254,['UBA3'],0.9264265917096351,0,0,1
359,Liver X receptor pathway WP2874,0.6485490567996429,1.023303916161059,0.44310863809940254,['SCD'],0.9264265917096351,0,0,1
360,Methylation Pathways WP704,0.6485490567996429,1.023303916161059,0.44310863809940254,['MAT2B'],0.9264265917096351,0,0,1
361,NAD Biosynthesis II (from tryptophan) WP2485,0.6485490567996429,1.023303916161059,0.44310863809940254,['NADSYN1'],0.9264265917096351,0,0,1
362,Urea cycle and related diseases WP4571,0.6485490567996429,1.023303916161059,0.44310863809940254,['SLC25A13'],0.9264265917096351,0,0,1
363,Endometrial cancer WP4155,0.6492140015262501,0.9113614362404294,0.39370164811769526,"['CCND1', 'APC', 'BAD', 'KRAS', 'PIK3CB', 'RAF1', 'FOXO3']",0.9264265917096351,0,0,7
364,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.6586334971110407,0.8951788303528274,0.3738159814947464,"['NTRK2', 'ROCK1', 'PIK3CB', 'GABRD']",0.933671433865159,0,0,4
365,IL17 signaling pathway WP2112,0.6594230291847878,0.8952294685990339,0.37276462036363195,"['TRAF3', 'SP1', 'MAP3K14']",0.933671433865159,0,0,3
366,Focal Adhesion WP306,0.6596983490244174,0.9278120713305898,0.3859443953289972,"['ROCK1', 'BAD', 'ACTN1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PARVA', 'VEGFD', 'PIK3CB', 'PTK2', 'ARHGAP35', 'PPP1CA', 'MYLK4', 'MAPK9', 'CCND1', 'CAPN2', 'RAC3', 'RAF1', 'PPP1R12B', 'PAK2', 'ITGA9']",0.933671433865159,0,0,21
367,15q13.3 copy number variation syndrome WP4942,0.665886958671043,0.8952800579430227,0.36405252380376835,"['CREBBP', 'OTUD7A']",0.9375674842992985,0,0,2
368,Toll-like Receptor Signaling Pathway WP75,0.669697274287161,0.8949757869249395,0.3588221930857927,"['MAPK9', 'TBK1', 'CHUK', 'TRAF3', 'TOLLIP', 'MAP3K8', 'PIK3CB', 'IKBKE']",0.9375674842992985,0,0,8
369,Development of ureteric collection system WP5053,0.6802001653054376,0.8679936142478434,0.3344971049520073,"['TGFB2', 'CCND1', 'RARB', 'SLIT2']",0.9375674842992985,0,0,4
370,PDGFR-beta pathway WP3972,0.6840372268320357,0.8593623188405797,0.3263367714601314,"['STAT5B', 'RASA1', 'RAF1']",0.9375674842992985,0,0,3
371,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6840372268320357,0.8593623188405797,0.3263367714601314,"['SERPINF1', 'P3H2', 'LRP6']",0.9375674842992985,0,0,3
372,ATR Signaling WP3875,0.6916231522757037,0.8953305984555985,0.3301209704518752,['RPA1'],0.9375674842992985,0,0,1
373,Estrogen Receptor Pathway WP2881,0.6916231522757037,0.8953305984555985,0.3301209704518752,['SP1'],0.9375674842992985,0,0,1
374,NLR Proteins WP288,0.6916231522757037,0.8953305984555985,0.3301209704518752,['CHUK'],0.9375674842992985,0,0,1
375,Role of Osx and miRNAs in tooth development WP3971,0.6916231522757037,0.8953305984555985,0.3301209704518752,['NOTCH2'],0.9375674842992985,0,0,1
376,Supression of HMGB1 mediated inflammation by THBD WP4479,0.6916231522757037,0.8953305984555985,0.3301209704518752,['CHUK'],0.9375674842992985,0,0,1
377,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.6951919992536418,0.8425597182378505,0.30632708909399375,"['APAF1', 'BAD']",0.9375674842992985,0,0,2
378,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6951919992536418,0.8425597182378505,0.30632708909399375,"['PIK3R4', 'ATG10']",0.9375674842992985,0,0,2
379,Imatinib and Chronic Myeloid Leukemia WP3640,0.6951919992536418,0.8425597182378505,0.30632708909399375,"['CDKN1B', 'FOXO3']",0.9375674842992985,0,0,2
380,RAS and bradykinin pathways in COVID-19 WP4969,0.6951919992536418,0.8425597182378505,0.30632708909399375,"['ROCK1', 'PRKG1']",0.9375674842992985,0,0,2
381,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6951919992536418,0.8425597182378505,0.30632708909399375,"['KRAS', 'RAF1']",0.9375674842992985,0,0,2
382,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6984038180838712,0.8640468004139267,0.31015634511478773,"['SMARCAL1', 'CDKN1B', 'CDH2', 'PTPRO', 'PARVA', 'PTK2', 'LRP6']",0.9375674842992985,0,0,7
383,Vitamin D Receptor Pathway WP2877,0.7004724875668601,0.8861396208969025,0.31546587287273803,"['CEBPA', 'TGFB2', 'CDKN1B', 'HILPDA', 'CLEC16A', 'TNFAIP3', 'CDKAL1', 'GXYLT2', 'HIF1A', 'CRACR2A', 'CCND1', 'DNER', 'SOSTDC1']",0.9375674842992985,0,0,13
384,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7007939291281932,0.842407528501976,0.2995107538831461,"['RB1', 'APAF1', 'FAF1', 'PAK2']",0.9375674842992985,0,0,4
385,Ferroptosis WP4313,0.7007939291281932,0.842407528501976,0.2995107538831461,"['PRNP', 'TFRC', 'ACSL3', 'FTL']",0.9375674842992985,0,0,4
386,Hematopoietic Stem Cell Differentiation WP2849,0.7007939291281932,0.842407528501976,0.2995107538831461,"['THRB', 'HMGN5', 'ITGA2B', 'MXI1']",0.9375674842992985,0,0,4
387,ESC Pluripotency Pathways WP3931,0.7066234464335395,0.8748194848582821,0.3037875070295914,"['SMAD4', 'APC', 'SELENOP', 'FZD6', 'DVL2', 'FZD9', 'LIFR', 'RAF1', 'SMAD5', 'BMPR1A', 'LRP6']",0.9375674842992985,0,0,11
388,MET in type 1 papillary renal cell carcinoma WP4205,0.7141712777442261,0.8422550442528245,0.28353038801178176,"['BAD', 'KRAS', 'PIK3CB', 'RAF1', 'PAK2', 'PTK2']",0.9375674842992985,0,0,6
389,Cytosolic DNA-sensing pathway WP4655,0.7160657528925488,0.8325086590796635,0.2780439747433023,"['TBK1', 'CHUK', 'DDX58', 'POLR3H', 'IKBKE']",0.9375674842992985,0,0,5
390,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['H3F3A', 'H2AFX']",0.9375674842992985,0,0,2
391,Globo Sphingolipid Metabolism WP1424,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['FUT1', 'ST6GALNAC6']",0.9375674842992985,0,0,2
392,Hippo-Yap signaling pathway WP4537,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['LATS1', 'MAP4K4']",0.9375674842992985,0,0,2
393,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['CERK', 'GALNT1']",0.9375674842992985,0,0,2
394,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['LDHA', 'PDHA1']",0.9375674842992985,0,0,2
395,Vitamin D in inflammatory diseases WP4482,0.7223350893304705,0.7956971940554751,0.2588133510284489,"['SMAD4', 'CHUK']",0.9375674842992985,0,0,2
396,Genes controlling nephrogenesis WP4823,0.7292182020228267,0.7955984970477724,0.25123590326984474,"['NOTCH2', 'SLIT2', 'CD36']",0.9375674842992985,0,0,3
397,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7292182020228267,0.7955984970477724,0.25123590326984474,"['VMP1', 'LATS1', 'FOXO3']",0.9375674842992985,0,0,3
398,ACE Inhibitor Pathway WP554,0.7294202628815006,0.7957957957957958,0.2510777282550777,['ATP6AP2'],0.9375674842992985,0,0,1
399,EDA signaling in hair follicle development WP3930,0.7294202628815006,0.7957957957957958,0.2510777282550777,['SOSTDC1'],0.9375674842992985,0,0,1
400,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.7294202628815006,0.7957957957957958,0.2510777282550777,['SP1'],0.9375674842992985,0,0,1
401,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.7294202628815006,0.7957957957957958,0.2510777282550777,['CCND1'],0.9375674842992985,0,0,1
402,Nanoparticle triggered regulated necrosis WP2513,0.7294202628815006,0.7957957957957958,0.2510777282550777,['FTL'],0.9375674842992985,0,0,1
403,Selective expression of chemokine receptors during T-cell polarization WP4494,0.7294202628815006,0.7957957957957958,0.2510777282550777,['TGFB2'],0.9375674842992985,0,0,1
404,Glycerolipids and Glycerophospholipids WP4722,0.7474058754404004,0.753767567155455,0.2194570910926155,"['PCYT2', 'AGPAT4']",0.9504025025240774,0,0,2
405,Pregnane X receptor pathway WP2876,0.7474058754404004,0.753767567155455,0.2194570910926155,"['NCOA3', 'PPARGC1A']",0.9504025025240774,0,0,2
406,Purinergic signaling WP4900,0.7474058754404004,0.753767567155455,0.2194570910926155,"['P2RX7', 'GNAI3']",0.9504025025240774,0,0,2
407,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7474058754404004,0.753767567155455,0.2194570910926155,"['GSK3A', 'BCL2L15']",0.9504025025240774,0,0,2
408,Zinc homeostasis WP3529,0.7498271414402761,0.7671325051759834,0.22086709653899592,"['SLC30A7', 'SLC30A1', 'MT3']",0.9504025025240774,0,0,3
409,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7567527324188816,0.7739474612360064,0.21571364602018483,"['UCHL1', 'SMAD4', 'CCND1', 'HIF1A']",0.9504025025240774,0,0,4
410,Alanine and aspartate metabolism WP106,0.7625865944268141,0.7161679536679537,0.19410959673850842,['GOT2'],0.9504025025240774,0,0,1
411,Biomarkers for urea cycle disorders WP4583,0.7625865944268141,0.7161679536679537,0.19410959673850842,['GAMT'],0.9504025025240774,0,0,1
412,Cells and molecules involved in local acute inflammatory response  WP4493,0.7625865944268141,0.7161679536679537,0.19410959673850842,['C5'],0.9504025025240774,0,0,1
413,Farnesoid X receptor pathway WP2879,0.7625865944268141,0.7161679536679537,0.19410959673850842,['PPARGC1A'],0.9504025025240774,0,0,1
414,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.7625865944268141,0.7161679536679537,0.19410959673850842,['NKRF'],0.9504025025240774,0,0,1
415,Purine metabolism WP4792,0.7625865944268141,0.7161679536679537,0.19410959673850842,['PRPS1'],0.9504025025240774,0,0,1
416,Interferon type I signaling pathways WP585,0.7650923620705411,0.7780569338154907,0.20833152690436957,"['RPTOR', 'RPS6KB1', 'PRMT1', 'RPS6', 'PTPN6']",0.9504025025240774,0,0,5
417,Pathogenic Escherichia coli infection WP2272,0.7650923620705411,0.7780569338154907,0.20833152690436957,"['TUBA1B', 'ROCK1', 'TUBB3', 'TUBB4B', 'TUBA4A']",0.9504025025240774,0,0,5
418,NAD+ biosynthetic pathways WP3645,0.7705044895806762,0.716030902945437,0.18667627163786288,"['BST1', 'NADSYN1']",0.9525568630138191,0,0,2
419,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7705044895806762,0.716030902945437,0.18667627163786288,"['SRXN1', 'GSTP1']",0.9525568630138191,0,0,2
420,Glucocorticoid Receptor Pathway WP2880,0.7738011572428125,0.7807890222984563,0.20022580327144368,"['FGD4', 'NAV3', 'ABHD2', 'PLK2', 'DNER', 'TNFAIP3']",0.9543547605994688,0,0,6
421,MAPK Cascade WP422,0.7872496524811172,0.7158937198067633,0.1712488368013101,"['MAP3K3', 'KRAS', 'RAF1']",0.9555824604193606,0,0,3
422,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7916892537940513,0.651017901017901,0.1520688760655368,['SMAD5'],0.9555824604193606,0,0,1
423,Disorders of Folate Metabolism and Transport WP4259,0.7916892537940513,0.651017901017901,0.1520688760655368,['SLC46A1'],0.9555824604193606,0,0,1
424,NO metabolism in cystic fibrosis WP4947,0.7916892537940513,0.651017901017901,0.1520688760655368,['PRMT1'],0.9555824604193606,0,0,1
425,Osteoclast Signaling WP12,0.7916892537940513,0.651017901017901,0.1520688760655368,['CTSK'],0.9555824604193606,0,0,1
426,Platelet-mediated interactions with vascular and circulating cells WP4462,0.7916892537940513,0.651017901017901,0.1520688760655368,['TGFB2'],0.9555824604193606,0,0,1
427,Serotonin and anxiety-related events WP3944,0.7916892537940513,0.651017901017901,0.1520688760655368,['NLGN1'],0.9555824604193606,0,0,1
428,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7917376376163103,0.6818882067554206,0.15923808510001006,"['SMAD2', 'SMAD4']",0.9555824604193606,0,0,2
429,Microglia Pathogen Phagocytosis Pathway WP3937,0.8041484483367001,0.6927536231884058,0.15100046990500374,"['RAC3', 'PTPN6', 'PIK3CB']",0.9555824604193606,0,0,3
430,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8041484483367001,0.6927536231884058,0.15100046990500374,"['RASA1', 'RAF1', 'PTK2']",0.9555824604193606,0,0,3
431,Tryptophan metabolism WP465,0.8041484483367001,0.6927536231884058,0.15100046990500374,"['PRMT1', 'AOX1', 'DHCR24']",0.9555824604193606,0,0,3
432,Prader-Willi and Angelman Syndrome WP3998,0.8074182566093433,0.7302727667469309,0.15621517370504984,"['RB1', 'HERC2', 'CCND1', 'GNRH1', 'GABRD']",0.9555824604193606,0,0,5
433,miRNAs involvement in the immune response in sepsis WP4329,0.8112154878212803,0.650849392037224,0.1361717211215071,"['CHUK', 'TRAF3']",0.9555824604193606,0,0,2
434,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8112154878212803,0.650849392037224,0.1361717211215071,"['OMG', 'MYT1']",0.9555824604193606,0,0,2
435,Signal Transduction of S1P Receptor WP26,0.8112154878212803,0.650849392037224,0.1361717211215071,"['GNAI3', 'PIK3C2B']",0.9555824604193606,0,0,2
436,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8120303616406467,0.7402532405785496,0.15413371490136277,"['RB1', 'CDKN1B', 'RPS6KB1', 'RPS6', 'GNAI3', 'RAF1']",0.9555824604193606,0,0,6
437,Development and heterogeneity of the ILC family WP3893,0.8172259265748586,0.5967261904761905,0.12044302955997144,['BCL11B'],0.9555824604193606,0,0,1
438,GPR40 Pathway WP3958,0.8172259265748586,0.5967261904761905,0.12044302955997144,['PKD1'],0.9555824604193606,0,0,1
439,Hedgehog Signaling Pathway Netpath WP47,0.8172259265748586,0.5967261904761905,0.12044302955997144,['ARNTL'],0.9555824604193606,0,0,1
440,IL-9 signaling pathway WP22,0.8172259265748586,0.5967261904761905,0.12044302955997144,['STAT5B'],0.9555824604193606,0,0,1
441,Major receptors targeted by epinephrine and norepinephrine WP4589,0.8172259265748586,0.5967261904761905,0.12044302955997144,['ADCY5'],0.9555824604193606,0,0,1
442,Nephrogenesis WP5052,0.8172259265748586,0.5967261904761905,0.12044302955997144,['NOTCH2'],0.9555824604193606,0,0,1
443,Omega-3/Omega-6 FA synthesis WP4723,0.8172259265748586,0.5967261904761905,0.12044302955997144,['ACSL3'],0.9555824604193606,0,0,1
444,Acute viral myocarditis WP4298,0.8345687705830321,0.71548137397194,0.12938774464526623,"['ENDOG', 'CCND1', 'RASA1', 'RAC3', 'DMD', 'EIF4G1']",0.9651585464214724,0,0,6
445,Cysteine and methionine catabolism WP4504,0.8396333718849177,0.5507870507870508,0.0962720380184618,['AHCY'],0.9651585464214724,0,0,1
446,FOXA2 pathway WP5066,0.8396333718849177,0.5507870507870508,0.0962720380184618,['MLXIPL'],0.9651585464214724,0,0,1
447,Kennedy pathway from sphingolipids WP3933,0.8396333718849177,0.5507870507870508,0.0962720380184618,['PCYT2'],0.9651585464214724,0,0,1
448,Leptin Insulin Overlap WP3935,0.8396333718849177,0.5507870507870508,0.0962720380184618,['INSR'],0.9651585464214724,0,0,1
449,miR-509-3p alteration of YAP1/ECM axis WP3967,0.8396333718849177,0.5507870507870508,0.0962720380184618,['SPARC'],0.9651585464214724,0,0,1
450,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.8396333718849177,0.5507870507870508,0.0962720380184618,['DDX58'],0.9651585464214724,0,0,1
451,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8453491384312039,0.5965314662803799,0.1002206002974071,"['RBL1', 'RAF1']",0.9651585464214724,0,0,2
452,Blood Clotting Cascade WP272,0.8592948777558646,0.5114106453392168,0.07755191385405333,['F8A1'],0.9651585464214724,0,0,1
453,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.8592948777558646,0.5114106453392168,0.07755191385405333,['PDLIM5'],0.9651585464214724,0,0,1
454,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.8592948777558646,0.5114106453392168,0.07755191385405333,['ROCK1'],0.9651585464214724,0,0,1
455,TP53 network WP1742,0.8592948777558646,0.5114106453392168,0.07755191385405333,['ATM'],0.9651585464214724,0,0,1
456,Tryptophan catabolism leading to NAD+ production WP4210,0.8592948777558646,0.5114106453392168,0.07755191385405333,['NADSYN1'],0.9651585464214724,0,0,1
457,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.8596260840181326,0.7152058111380145,0.10818043630324596,"['COX8A', 'NDUFB9', 'SURF1', 'NDUFS4', 'NDUFS3', 'SLC25A4', 'COX5A', 'ATP5F1D']",0.9651585464214724,0,0,8
458,Ethanol effects on histone modifications WP3996,0.8602231931385796,0.5726315789473684,0.08621735546978299,"['AHCY', 'HDAC1']",0.9651585464214724,0,0,2
459,Monoamine GPCRs WP58,0.8602231931385796,0.5726315789473684,0.08621735546978299,"['CHRM3', 'CHRM1']",0.9651585464214724,0,0,2
460,Resistin as a regulator of inflammation WP4481,0.8602231931385796,0.5726315789473684,0.08621735546978299,"['CHUK', 'PIK3CB']",0.9651585464214724,0,0,2
461,Prostaglandin Synthesis and Regulation WP98,0.8608170819434754,0.613416149068323,0.09193466910685943,"['ANXA4', 'ANXA5', 'PPARGC1A']",0.9651585464214724,0,0,3
462,Vitamin B12 metabolism WP1533,0.8608170819434754,0.613416149068323,0.09193466910685943,"['MTRR', 'INSR', 'HBA1']",0.9651585464214724,0,0,3
463,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8642253242211364,0.6624310480693459,0.09666309928290655,"['IFI27L2', 'MAPK9', 'SP1', 'PRKCE', 'KRAS']",0.9668870797981611,0,0,5
464,Corticotropin-releasing hormone signaling pathway WP2355,0.8738653269600706,0.6858067339442242,0.09246663842551878,"['MAPK9', 'PRKCI', 'SP1', 'GNB2', 'ARRB2', 'RAF1', 'PTK2']",0.9755651710459409,0,0,7
465,Serotonin and anxiety WP3947,0.8765468043902062,0.47728442728442727,0.06288946697190884,['GRM1'],0.9760813680558081,0,0,1
466,Heart Development WP1591,0.8861076730346215,0.5301428903553481,0.06410318642164972,"['SMAD4', 'BMPR1A']",0.9760813680558081,0,0,2
467,Complement Activation WP545,0.8916843273938698,0.4474239864864865,0.05129407376174046,['C5'],0.9760813680558081,0,0,1
468,"GPCRs, Class B Secretin-like WP334",0.8916843273938698,0.4474239864864865,0.05129407376174046,['ADGRL3'],0.9760813680558081,0,0,1
469,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.8916843273938698,0.4474239864864865,0.05129407376174046,['ACSL3'],0.9760813680558081,0,0,1
470,PPAR-alpha pathway WP2878,0.8916843273938698,0.4474239864864865,0.05129407376174046,['CCND1'],0.9760813680558081,0,0,1
471,PI3K-Akt signaling pathway WP4172,0.8972872345573858,0.7898959184654584,0.08560832823554507,"['PRKAA1', 'CDKN1B', 'PHLPP1', 'CHRM1', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3CB', 'FOXO3', 'RPTOR', 'CCND1', 'PPP2R1A', 'NTRK1', 'NTRK2', 'CHUK', 'BAD', 'INSR', 'RPS6', 'VEGFD', 'PTK2', 'CREB3', 'EFNA3', 'RPS6KB1', 'GNB2', 'KRAS', 'RAF1', 'ITGA9']",0.9760813680558081,0,0,27
472,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8973140299832927,0.5111747258053391,0.05538546922485691,"['CHUK', 'CBLB']",0.9760813680558081,0,0,2
473,GABA receptor Signaling WP4159,0.8973140299832927,0.5111747258053391,0.05538546922485691,"['GABRD', 'GPHN']",0.9760813680558081,0,0,2
474,Tumor suppressor activity of SMARCB1 WP4204,0.8973140299832927,0.5111747258053391,0.05538546922485691,"['RB1', 'H3F3A']",0.9760813680558081,0,0,2
475,Nuclear Receptors Meta-Pathway WP2882,0.8985785203472447,0.7788633036070811,0.08329256549421517,"['GSTM4', 'TGFB2', 'CDKN1B', 'SRXN1', 'NCOA6', 'PLK2', 'NCOA3', 'GSTP1', 'ABHD2', 'AIP', 'TNFAIP3', 'ARNT', 'PTPA', 'FGD4', 'CCND1', 'NAV3', 'SP1', 'SCD', 'PRDX1', 'DNER', 'ME1', 'EP300', 'PPARGC1A', 'FTL']",0.9760813680558081,0,0,24
476,PPAR signaling pathway WP3942,0.9031624539818814,0.5839358459671931,0.05947552254022316,"['SCD', 'ME1', 'CD36', 'ACSL3']",0.9760813680558081,0,0,4
477,Apoptosis Modulation by HSP70 WP384,0.9049664788738884,0.42107653872359757,0.04204759820433436,['APAF1'],0.9760813680558081,0,0,1
478,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9049664788738884,0.42107653872359757,0.04204759820433436,['TGFB2'],0.9760813680558081,0,0,1
479,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.9049664788738884,0.42107653872359757,0.04204759820433436,['IDH3A'],0.9760813680558081,0,0,1
480,Cardiac Progenitor Differentiation WP2406,0.9074855059009481,0.4935147105346409,0.04790926533069003,"['TNNT2', 'THY1']",0.9760813680558081,0,0,2
481,Fluoropyrimidine Activity WP1601,0.9074855059009481,0.4935147105346409,0.04790926533069003,"['DPYD', 'TK1']",0.9760813680558081,0,0,2
482,miRNA targets in ECM and membrane receptors WP2911,0.9166205703684592,0.39765658515658514,0.0346206444515855,['LAMA4'],0.9760813680558081,0,0,1
483,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.9166205703684592,0.39765658515658514,0.0346206444515855,['ATF1'],0.9760813680558081,0,0,1
484,Fatty acid beta-oxidation WP143,0.9167073350465352,0.4770320296153227,0.04148605046740031,"['HADHB', 'ACSL3']",0.9760813680558081,0,0,2
485,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9179372690785517,0.5609605852974345,0.04803293731167686,"['STAT5B', 'TGFB2', 'CALM1', 'BMPR1A']",0.9760813680558081,0,0,4
486,Endochondral Ossification WP474,0.9179372690785517,0.5609605852974345,0.04803293731167686,"['STAT5B', 'TGFB2', 'CALM1', 'BMPR1A']",0.9760813680558081,0,0,4
487,Nucleotide Excision Repair WP4753,0.918854874698561,0.5234358430540828,0.04429684991606477,"['CUL4A', 'RPA1', 'ERCC5']",0.9760813680558081,0,0,3
488,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9195515590950472,0.5861369185401275,0.049158813078304574,"['RPTOR', 'MAPK9', 'CREBBP', 'AKT1S1', 'LIFR']",0.9760813680558081,0,0,5
489,Alpha 6 Beta 4 signaling pathway WP244,0.9250594104606042,0.46161274746499276,0.035958394062247795,"['LAMA3', 'PTK2']",0.9798087092848032,0,0,2
490,Triacylglyceride synthesis WP325,0.9268460763504895,0.3767018898597846,0.028617203330795662,['AGPAT4'],0.9798087092848032,0,0,1
491,p38 MAPK Signaling Pathway WP400,0.9326163128129528,0.44715717044905845,0.0311943115735988,"['TGFB2', 'MKNK1']",0.9818963160903541,0,0,2
492,Eicosanoid Synthesis WP167,0.9358180414145209,0.3578426640926641,0.023737214578169987,['PTGES2'],0.9818963160903541,0,0,1
493,Kallmann's Syndrome WP5074,0.9358180414145209,0.3578426640926641,0.023737214578169987,['GNRH1'],0.9818963160903541,0,0,1
494,Apoptosis WP254,0.9364030504799902,0.558548416344294,0.036701817468544756,"['APAF1', 'CHUK', 'TRAF3', 'BAD', 'TNFRSF21']",0.9818963160903541,0,0,5
495,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9394474123288953,0.4335776890098474,0.02708275214162633,"['MAPK9', 'RAF1']",0.9830985042148844,0,0,2
496,1q21.1 copy number variation syndrome WP4905,0.9436900710110341,0.34077955506526936,0.019750724707371905,['PRKAA1'],0.9835642993636129,0,0,1
497,Unfolded protein response WP4925,0.9436900710110341,0.34077955506526936,0.019750724707371905,['HSPA5'],0.9835642993636129,0,0,1
498,Neural Crest Differentiation WP2064,0.9465014588820151,0.5642426094263234,0.03102361991993566,"['CDH6', 'NOTCH2', 'CDH2', 'HDAC1', 'DVL2', 'CDH7']",0.9845135656644254,0,0,6
499,Complement system WP2806,0.9500161231813357,0.5334305262854009,0.02735235583677632,"['PRNP', 'C5', 'ITGA2B', 'GNAI3', 'ARRB2']",0.9848184467475992,0,0,5
500,DNA Mismatch Repair WP531,0.9505969563200765,0.3252676377676378,0.016479722812808767,['RPA1'],0.9848184467475992,0,0,1
501,Allograft Rejection WP2328,0.953935523666143,0.45642923219241444,0.02152483519818806,"['TUBA1B', 'C5', 'LRRK2']",0.9851855155875948,0,0,3
502,Vitamin A and carotenoid metabolism WP716,0.9562050000189966,0.3973657385052846,0.017795211490252726,"['RARB', 'CD36']",0.9851855155875948,0,0,2
503,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.9566569774914289,0.3111045828437133,0.013785164465023462,['RARB'],0.9851855155875948,0,0,1
504,Cannabinoid receptor signaling WP3869,0.9619739254963833,0.2981217824967825,0.011557565336593498,['MAPK9'],0.9862453770374005,0,0,1
505,Glycosylation and related congenital defects WP4521,0.9619739254963833,0.2981217824967825,0.011557565336593498,['DPAGT1'],0.9862453770374005,0,0,1
506,DNA Repair Pathways Full Network WP4946,0.9633979937855687,0.5842626849894291,0.021786376829404458,"['CUL4A', 'RAD52', 'BRIP1', 'MRE11', 'H2AFX', 'USP1', 'RPA1', 'ATM', 'ERCC5']",0.9862453770374005,0,0,9
507,Oxidative Stress WP408,0.9707317468387755,0.2751522126522127,0.00817342776180707,['SP1'],0.9900145367224373,0,0,1
508,B Cell Receptor Signaling Pathway WP23,0.9713467659386609,0.5102287649457461,0.014833244093775021,"['MAPK9', 'GSK3A', 'CHUK', 'PTPN6', 'RAF1', 'MALT1']",0.9900145367224373,0,0,6
509,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.9743226640686857,0.2649435149435149,0.006891910192483343,['CCND1'],0.9900145367224373,0,0,1
510,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9747247369274963,0.34878873173087116,0.00892905045821256,"['RB1', 'CCND1']",0.9900145367224373,0,0,2
511,"GPCRs, Class A Rhodopsin-like WP455",0.9819415983377343,0.5352107558139535,0.009753383535087394,"['CHRM3', 'RABGAP1', 'CHRM1', 'NPY2R', 'GPR63', 'NPY1R', 'OPRL1', 'OPRM1', 'SSTR3']",0.9942056180721182,0,0,9
512,Metapathway biotransformation Phase I and II WP702,0.9843879302404854,0.5097544102386717,0.008021098592415274,"['GSTM4', 'GSTO1', 'GSTP1', 'CHST1', 'KCNAB1', 'NAT8L', 'NAT14', 'CHST2']",0.9942056180721182,0,0,8
513,NRF2 pathway WP2884,0.9846090387470977,0.48985915760302184,0.007598024919284299,"['GSTM4', 'TGFB2', 'SRXN1', 'PRDX1', 'GSTP1', 'ME1', 'FTL']",0.9942056180721182,0,0,7
514,Oxidation by Cytochrome P450 WP43,0.9920965562272388,0.19858697983697984,0.0015757562144328972,['CYB5R4'],0.9975676529179465,0,0,1
515,Lung fibrosis WP3624,0.9930665676564785,0.19320672023374727,0.0013442512645278966,['RTEL1'],0.9975676529179465,0,0,1
516,Complement and Coagulation Cascades WP558,0.9968395897503336,0.16618029990123012,0.0005260295962980591,['CLTC'],0.9975676529179465,0,0,1
517,One-carbon metabolism and related pathways WP3940,0.9975676529179465,0.15877305877305878,0.0003866616247191241,['PCYT2'],0.9975676529179465,0,0,1
518,TYROBP causal network in microglia WP3945,0.9975676529179465,0.15877305877305878,0.0003866616247191241,['DPYD'],0.9975676529179465,0,0,1
